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ABSTRACT OF DISSERTATION 
 
 
 
 
INSIGHTS INTO EXPRESSION, CELLULAR LOCALIZATION, AND REGULATION OF 
SUPERNATANT PROTEIN FACTOR, A PUTATIVE REGULATOR OF CHOLESTEROL 
BIOSYNTHESIS 
 
SPF (Supernatant Protein Factor) is a cytosolic protein that stimulates at least two 
enzymes in the cholesterol biosynthetic pathway: squalene monooxygenase and HMG-
CoA reductase.  The mechanism of action has not been established but may be related 
to lipid transfer between intracellular membranes. 
There are three human genes for SPF: SEC14L2 (SPF1), SEC14L3 (SPF2) and SEC14L4 
(SPF3).  The present study differentiates these closely related genes by evaluating their 
tissue-specific and relative expression levels.  SPF1 mRNA was found to be most 
abundant in liver, mammary gland and stomach.  SPF2 showed negligible expression in 
all tissues tested; SPF3 expression pattern was similar to that of SPF1, but at 10-50-fold 
lower levels than SPF1.   
A cDNA to SPF3 was cloned and, upon transfection into rat hepatoma cells, was shown 
to increase cholesterol synthesis by approximately 50%, similar to that obtained with 
SPF1.  However, in contrast to SPF1, SPF3 did not stimulate squalene monooxygenase 
activity in microsomal preparations, suggesting that it acts primarily through activation 
of HMG-CoA reductase.   
SPF possesses a lipid binding domain (Sec14) and a Golgi dynamics domain (GOLD).  SPF 
resides in the cytosol and requires phosphorylation and the presence of Golgi in order to 
stimulate cholesterol synthesis.  To determine if SPF associates with specific subcellular 
structures, cellular immunofluorescence studies were carried out.  A phosphorylation-
defective mutant, a protein lacking the GOLD domain, and the effect of protein kinase 
A-mediated phosphorylation of endogenous SPF were examined.  No change in the 
subcellular location of SPF could be detected with either the phosphorylation mutant or 
the native SPF after protein kinase A activation.  However, removal of the GOLD domain 
resulted in a protein that co-localized with large vesicular structures around nucleus. 
 
 
Studies with rat hepatoma cells showed that the expression of the two rat SPF genes is 
upregulated in response to serum deprivation, and is potentiated by removal of glucose.  
Lipid/cholesterol availability was demonstrated to be at least one of the serum 
components that affected SPF transcript levels.  The oxysterol receptor LXR was shown 
not to be involved in SPF gene regulation, implicating SREBP and/or PPARα as the 
principal regulators of SPF gene transcription.  
 
KEYWORDS: Supernatant Protein Factor, Cholesterol, Lipid Binding Domain, Golgi 
Dynamics Domain, Immunofluorescence 
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Chapter 1 : INTRODUCTION 
 
 
Why is cholesterol important?  
 
It has been proposed that the availability of molecular oxygen gave rise to eukaryotic 
life and significantly impacted the evolution of species 1.  Konrad Bloch, who was 
awarded a Nobel prize for delineating the enzymatic steps in the cholesterol 
biosynthetic pathway, showed that it was very unlikely for squalene to become cyclized 
to lanosterol without molecular oxygen and even less likely for subsequent conversion 
of lanosterol to cholesterol 1.  Therefore it has been postulated that availability of 
molecular oxygen made the synthesis of cholesterol possible.  Bloch, impressed with the 
particular sequence of systematic enzymatically controlled reactions following 
cyclization of squalene to lanosterol, proposed that evolutionary pressure demanded 
the formation of cholesterol to satisfy the physical requirements of plasma membranes 
in eukaryotic cells.  In fact, the influence of various sterols on membrane 
“microviscosity” was examined in vitro and a systematic increase in membrane 
microviscosity was found progressing from lanosterol to cholesterol 1.  It was also 
postulated that certain membrane-related events unique to eukaryotes, such as endo- 
and exo-cytosis, became possible due to the appearance of cholesterol.  Taken together, 
cholesterol is viewed as a crucial molecule in the evolution of membranes and, 
moreover, eukaryotic life 1; 2
Cholesterol markedly influences plasma membrane thermomechanical properties 
.  
2.  As 
an amphipathic molecule, cholesterol is able to intercalate into the lipid bilayer with its 
small hydrophilic head group and increase lipid order in fluid membranes to maintain 
fluidity and alter the phase transition.  Cholesterol also increases bilayer thickness and 
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decreases membrane permeability.  Cholesterol also plays an important role in lateral 
organization of the membrane by formation of lipid rafts, which are areas of specific 
lipid-protein composition involved in signal transduction.  The cholesterol molecule 
itself is involved in cellular signaling, in that certain proteins respond to cholesterol 
levels through their sterol sensing domains, to influence cholesterol synthesis and 
metabolism 2
In higher eukaryotes cholesterol is either synthesized in cells, with liver and intestine 
being major sites of production, or is absorbed in the gut from food.  Blood transports 
cholesterol in the form of lipoprotein particles.  Cholesterol absorbed from food is 
transported from the small intestine to peripheral tissues and ultimately the liver as 
chylomicron particles.  Exogenous and newly synthesized cholesterol constitutes the 
liver’s pool of cholesterol.  Hepatocytes utilize cholesterol by incorporating it into the 
plasma membrane and for bile acid synthesis.  Free cholesterol is esterified, packaged 
into VLDL particles and secreted into the bloodstream.  In blood, VLDL particles are 
.  In addition, early in development certain signaling molecules from the 
Hedgehog family of morphogens are covalently modified by cholesterol. 
A variety of physiologically important molecules are derived from cholesterol: Vitamin 
D, which maintains calcium homeostasis; bile acids, which are necessary for 
solubilization and absorption of dietary fats; sex steroids responsible for sexual 
differentiation and maintenance of reproductive functions; and the hormones of the 
adrenal cortex: mineralocorticoids, involved in salt and water homeostasis, and 
glucocorticoids, regulators of growth, metabolism, and the response to stress and 
inflammation. 
Apart from cholesterol, some intermediates of the pathway serve as precursors for the 
synthesis of various non-steroidal isoprenoids.  For example, farnesyl or geranylgeranyl 
groups anchor certain proteins to the membrane (Ras, Rho, Rab etc.); dolichol takes part 
in glycoprotein synthesis; and ubiquinone and heme A are constituents of the 
respiratory chain complexes. 
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reduced to more dense LDL particles and in this form cholesterol is distributed 
throughout the body.  In peripheral tissues cholesterol is taken up by cells via LDL or 
scavenger receptors.  Cells incorporate it into the plasma membrane and may use it for 
the synthesis of steroid hormones.  Excess cholesterol is incorporated into HDL 
lipoproteins and for transport back to the liver.  The liver is able to take up all 
lipoprotein particles: chylomicrons, LDL and HDL.  Bile acids produced in the liver are 
secreted into the bile and stored in the gallbladder to be released into intestine to 
solubilize dietary lipids.  Bile acids are then either reabsorbed and returned to liver or 
excreted.  Excretion of bile acids is the only route of cholesterol removal from the 
organism. 
Maintenance of a balanced lipid profile is crucial for health.  Elevated levels of LDL and 
low level of HDL lipoproteins are associated with atherosclerosis and coronary heart 
disease, a major cause of death in western societies.    
 
Cholesterol biosynthetic pathway 
 
The cholesterol biosynthetic pathway is of major importance for animal and human 
physiology.  It gives rise to cholesterol, steroidal derivatives and non-steroidal 
isoprenoids.   
Cholesterol synthesis occurs in eukaryotic cells from the two carbon molecule acetate, 
esterified to coenzyme A, in a series of condensation reactions.  In cytosol three 
molecules of acetyl-CoA are condensed to form 3-hydroxy-3-methylglutaryl-CoA (HMG-
CoA) which is then reduced to form mevalonate.  This reduction is catalyzed by HMG-
CoA reductase and it is the principal regulatory step in the pathway.  Subsequently, 
mevalonate is phosphorylated to form several active intermediates and then 
decarboxylated to form the 5-carbon isoprenoid isopentenyl pyrophosphate (IPP).  IPP is 
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in equilibrium with its isomer dimethylallyl pyrophosphate (DMPP) and these two 
molecules condense to form geranyl pyrophosphate (GPP).  GPP condenses with 
another molecule of IPP to yield farnesyl pyrophosphate (FPP), a 15-carbon molecule.  
Squalene synthase then catalyzes the condensation of two FPP molecules to yield 
squalene, a 30-carbon molecule that is subsequently oxidized to 2,3-oxidosqualene by 
squalene monooxygenase in presence of molecular oxygen and NADPH.  This 
epoxidation of squalene is the first oxygen-requiring step in cholesterol synthesis, and is 
followed by a cascade of electron shifts resulting in cyclization, all catalyzed by 
oxidosqualene cyclase and yielding the characteristic steroid ring structure: lanosterol.  
Conversion of lanosterol to cholesterol involves 19 steps, including a series of reduction 
and demethylation reactions, all taking place in the membranes of endoplasmic 
reticulum.  
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Figure 1.1: Cholesterol biosynthetic pathway. 
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Stimulatory effect of supernatant fluid on cholesterol biosynthesis 
 
The first report on the ability of “supernatant fluid” (i.e., the 100,000 x g  supernatant 
fraction of a tissue homogenate, equivalent to the cell cytosol) to activate the 
cyclization of squalene to lanosterol appeared during an investigation on cholesterol 
biosynthetic pathway in the Konrad Bloch laboratory 3.  This cyclization occurs in two 
steps; first squalene monooxygenase epoxidizes squalene to 2,3-oxidosqualene, 
followed by cyclization to lanosterol catalyzed by oxidosqualene cyclase 3; 4. It was shown 
with microsomal assays that the liver 100,000 x g supernatant fraction stimulates 
membrane-bound squalene monooxygenase.  Subsequently it was determined that this 
supernatant fraction provides two essential components, one heat-stable and one heat-
labile 5.  The heat-labile component proved to be a protein, which was purified and 
termed Supernatant Protein Factor (SPF).  The heat-stable components of the supernate 
could be replaced by anionic phospholipids (phosphatidylinositol, phosphatidylserine, 
phosphatidylglycerol) and FAD 6.  Solubilized squalene monooxygenase, while 
enzymatically active, did not respond to SPF and phospholipids, and therefore it was 
concluded that intact membrane is required to observe this stimulation.  The apparent 
requirement for an intact membrane suggested a  substrate- or product-carrier function 
for SPF, but binding to substrate (squalene) or product (2,3-oxidosqualene) could not be 
shown 7.  Later it was found that SPF also stimulates the subsequent step, conversion of 
squalene 2,3-epoxide to lanosterol, mediated by oxidosqualene cyclase 8.  In this light, 
SPF seemed to influence intramembrane events rather than act as a carrier protein.  
Presumably, together with anionic phospholipids, SPF affects some membrane 
properties or membrane-associated events which influence the activity of these 
enzymes 9.  In 1980 Friedlander et al. 10 demonstrated that SPF facilitates the 
intramembrane transfer of squalene in in vitro preparations.  The mechanism by which 
this cytosolic protein directs movement of lipophilic substrate across or between 
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bilayers remained obscure, but it was proposed that it must involve direct interaction 
with the surface of another membrane or particle 10
Structural features of SPF 
. 
 
 
In 2000 a novel human ‘tocopherol-associated protein’ (TAP) was cloned, expressed, 
and characterized 11, soon after the cloning of human SPF was reported 12; 13.  It wasn’t  
recognized until later that TAP and SPF are in fact the same entity 13. Supernatant 
Protein Factor/SEC14-like protein 2/Alpha-Tocopherol-Associated Protein 
(SPF/Sec14l2/TAP) is a 403-amino acid protein found in the cytosol of mammalian cells.  
The determination of the SPF primary sequence allowed for sequence comparison 
studies; a BLAST alignment with the database of known protein sequences revealed 
conserved domains within Sec14l2 protein (SPF) as depicted in the schematic figure 
below (Fig.1.2) 
 
 
Figure 1.2: Conserved domains of SPF protein.  
 
Soon after cloning and expression of SPF, the three-dimensional structure was published 
(Fig. 1.3.) 14. 
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Figure 1.3: Crystal structure of human supernatant protein factor as a ribbon diagram.  
The lipid binding cavity is shown in grey, the CRAL/TRIO_N domain in navy, the Sec14 
domain in turquoise-green, and the GOLD domain in yellow-orange (as on the scheme in 
Fig. 1.2).  Taken from reference 14
 Sec14-like proteins were named after their main protein module: Sec14 domain 
(smart00516).  Sec14 is a conserved domain known to bind small lipid molecules, 
including phosphatidylinositol, retinol, and α-tocopherol.  This domain is found in a 
number of secretory proteins, such as S. cerevisiae phosphatidylinositol transfer protein 
. 
 
Further sequence alignments with the database found presumed homologues in several 
species and various proteins that share the same domains.  There are three highly 
similar SPF proteins in the human genome: hSPF1 (TAP1, Sec14-like 2 protein), hSPF2 
(TAP2, Sec14-like 3 protein), and hSPF3 (TAP3, Sec14-like 4 protein).  Two proteins in the 
rat genome also show high similarity: rSPF (rSec14l2) and p45 (rSec14l3, rat SPF-like 
protein), a 45-kDa secretory protein from rat olfactory epithelium. 
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(Sec14p), and multiple lipid-regulated proteins: Cellular Retinal Binding Protein 
(CRALBP), Tocopherol Transfer Protein (α-TTP), RhoGAPs, RhoGEFs, PTPMEG2, and 
others.  The Sec14 domain of PTPMEG2 was found to contain motifs necessary for 
targeting to the secretory vesicles 15, which might be an additional function besides lipid 
binding that this domain possesses.  The all-α N-terminal portion of this domain was 
recently annotated in the NCBI database as a separate protein module: CRAL/TRIO_N 
domain (pfam03765); this domain is absent in some members of the Sec14 family, such 
as CGR-1.  The carboxy-terminal part of Sec14-like proteins contains a β-strand-rich 
protein module, named the GOLD domain (for Golgi Dynamics) (pfam01105).  This 
domain is proposed to mediate protein-protein interactions.  The GOLD domain of the 
GCP60 protein was shown to interact with Golgi residual protein giantin 16.  It is the main 
domain of members of the emp24/gp25L/p24 family, which are proteins involved in 
Golgi processing and secretion.  P24 proteins are critical components of coated vesicles, 
bringing cargo forward from the endoplasmic reticulum to the Golgi.  The GOLD domain 
is always found combined with a lipid-binding domain (CRAL/TRIO, Sec14, or OxB) or 
with membrane-association domains (PH, FYVE) 17-19.  Interestingly, a recently 
characterized CGR-1 protein from C. elegans is the only other known protein that, like 
the SPF proteins, contains both Sec14 and GOLD domains.  CGR-1 positively regulates 
Ras signaling during C. elegans vulvae development 20.  
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Figure 1.4: Schematic representation of a few proteins from the Sec14 protein family.  
 
The availability of the SPF nucleotide sequence facilitated the cloning of a cDNA to SPF 
and expression of the recombinant protein.  Recombinant, bacterially expressed SPF 
was able to stimulate the transfer of squalene and activity of squalene monooxygenase 
in microsomal preparations 12; 21.  Hepatoma cells transfected with a plasmid carrying the 
SPF cDNA expressed the recombinant human protein and showed a 2-3 fold increase in 
cholesterol synthesis, extending earlier studies with purified proteins in reconstituted 
systems 12; 22. 
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Three human SPF genes  
 
As noted above, there are three highly similar genes encoding SPF-like proteins in the 
human genome: SPF1, SPF2 and SPF3.  The degree of identity to SPF1 at the protein 
level is 77% for SPF2 and 70% for SPF3, as shown in Fig. 1.4.  The degree of identity to 
SPF1 at the mRNA level is 66% for SPF2 and 59% for SPF3 (full alignment of these 
transcripts is shown in Fig. 2.1).  The SPF protein that has been the most studied so far is 
SPF1 (NP_036561), also referred to as SEC14-like 2, tocopherol-associated protein (TAP), 
or simply SPF.  Human SPF2 (NP_777635) is also called SEC14-like 3, and SPF3 
(NP_777637.1) is SEC14-like 4. 
 
Stimulation of HMG-CoA Reductase by SPF 
 
Studies in the 1970’s and 1980’s indicated that SPF stimulated the conversion of 
squalene to lanosterol.  This conversion can be broken down to epoxidation of squalene 
to 2,3-oxidosqualene catalyzed by squalene monooxygenase, and cyclization of 
oxidosqualene to lanosterol catalyzed by oxidosqualene cyclase.  As mentioned earlier, 
SPF was shown to stimulate both enzymes.  Later, studies with hepatoma cells 
transfected with SPF showed that the increase in cholesterol synthesis when measured 
with [14C]-mevalonate was less than that obtained with [14C]-acetate 23.  This unexpected 
finding suggested that part of the SPF stimulation was at or upstream of HMG-CoA 
reductase, the enzyme that generates mevalonate.  To explore this possibility, 
terbinafine, an inhibitor of squalene monooxygenase, was used to block the conversion 
of squalene to cholesterol in SPF-transfected cells; under these conditions the synthesis 
of squalene was increased when measured from [14C]-acetate and was unchanged when 
measured with [14C]-mevalonate.  This finding further indicated a stimulatory effect of 
12 
 
SPF on mevalonate synthesis.  There are only 3 steps in the pathway between acetate 
and mevalonate: the condensation of two acetate molecules catalyzed by β-
ketothiolase, followed by synthesis of 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) by 
HMG-CoA synthase, and reduction of HMG-CoA mediated by HMG-CoA reductase.  A 
stimulatory effect on HMG-CoA reductase was confirmed in microsomal assays by 
measurement of mevalonate synthesis from HMG-CoA in presence or absence of SPF 
protein 23. Although it was not investigated if β-ketothiolase or HMG-CoA synthase is 
also affected by SPF, it was suggested that HMG-CoA reductase is the main target, as 
this is the main regulatory enzyme of the pathway 23
Requirement for Golgi in SPF function 
. 
 
 
Knowledge of SPF structural motifs has allowed for structure-function studies to be 
undertaken.  Deletion of the GOLD domain resulted in a protein that was no longer able 
to stimulate cholesterol synthesis 22.  The GOLD domain has been suggested to be 
involved in interaction with Golgi, and therefore it was argued that an interaction of SPF 
with Golgi was necessary for SPF stimulatory effect.  This suggestion was supported by 
studies with brefeldin-A, which disrupts Golgi structures: The stimulatory effect of SPF 
on cholesterol synthesis was abolished when Golgi were disrupted with this agent 22.  
Moreover, washout of brefeldin-A, which allows for Golgi reassembly, resulted in a re-
gain of SPF activity.  This clearly demonstrated that SPF requires Golgi for its function, 
although the nature of the interaction between SPF and Golgi remains to be elucidated.  
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SPF activation by phosphorylation 
 
It was observed in our laboratory that addition of ATP to microsomes increases the 
stimulatory effect of SPF on squalene monooxygenase 21.  This finding was further 
explored by treatments with a variety of protein kinase inhibitors and protein kinases 
themselves.  It was concluded that both protein kinase A and C are capable of SPF 
phosphorylation.  Cell culture studies with  dibutyryl-cAMP, a PKA stimulator, confirmed 
that SPF needs to be activated by PKA to achieve its full activity 21.  Cell-permeable 
protein kinase A inhibitor 14-22 amide was further able to prevent this activation of SPF.  
Phosphorylation appeared to increase the SPF stimulation of both squalene 
monooxygenase and HMG–CoA reductase.  Moreover, sequence analysis of SPF 
revealed the presence of a putative protein kinase A (PKA) phosphorylation site within 
the coding sequence.  Substitution of the serine in position 289 with alanine resulted in 
a  protein unable to stimulate cholesterol synthesis in cell culture when compared with 
wild-type protein 22
Dose response curve for SPF 
. 
 
 
In vitro assays showed that the amount of SPF used in the assay is critical.  SPF activity 
increases with an increase in the amount of protein present, reaching its maximum at 
0.8 μg per incubation, and then quickly declining, resulting in total loss of stimulation.  It 
was shown that the SPF activation curve is similar for both enzymes, squalene 
monooxygenase and HMG–CoA reductase.  
These two observations of similar behavior of SPF led to the suggestion that the 
mechanism of stimulation is similar for both enzymes.  Since SPF stimulates at least 
three enzymes, HMG-CoA reductase, squalene monooxygenase, and oxidosqualene 
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cyclase, it can be argued that the mechanism by which SPF acts is through a general, 
membrane-dependent event.  
 
SPF-null mice 
 
Despite the many possible roles for SPF in cellular and organismal biology, SPF (-/-) null 
mice did not show an abnormal phenotype, and developed normally 24.  Notably, plasma 
lipids levels were unchanged despite elevated levels of HMG-Co A synthase and 
squalene monooxygenase in liver.  However, during fasting plasma cholesterol levels 
decreased significantly in SPF-null mice, but not in wild-type mice.  Fasting decreased 
hepatic cholesterol synthesis in both wild-type and SPF-null animals, but with a greater 
reduction in SPF-null mice.  The decrease in cholesterol synthesis during fasting was 
accompanied by a pronounced decrease in the expression of cholesterolgenic enzymes: 
HMG-CoA synthase, HMG-CoA reductase and squalene monooxygenase in both wild-
type and SPF-null mice.  Interestingly, in fasted wild-type mice, the expression of SPF 
mRNA and protein was elevated.  Since PPARα is known to play a role in hepatic 
response to fasting 25; 26
The data from SPF-null mice strongly suggests that SPF is upregulated upon fasting to 
compensate, at least partially, for the decrease in cholesterol synthesis.  The reason for 
this compensatory increase is not apparent.  Treatment with fibrates, which are PPARα 
agonists, also resulted in upregulation of SPF protein expression.  The same treatments 
in PPARα-null mice did not elevate SPF, indicating a PPARα dependency.  Fibrates are 
used to lower plasma triglyceride levels; here it was shown that administration of 
fibrates to SPF-null mice resulted in significant reduction in plasma cholesterol levels as 
, PPARα-null mice were subjected to fasting and did not show an 
increase in SPF expression upon treatment.  It was therefore concluded that the 
increase in SPF protein expression during fasting is dependent on PPARα.  
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well, suggesting that coadministration of a fibrate and an SPF antagonist, if one can be 
discovered, could be beneficial for improving the plasma lipids profile 24
Possible Ligands for SPF 
.  
 
 
Since SPF stimulates microsomal squalene monooxygenase and appears to promote 
intermembrane transfer of squalene, it was postulated early on that SPF is a squalene 
transfer protein.  However, multiple attempts to show squalene binding were 
unsuccessful, or showed only weak affinity, likely not sufficient for direct transfer of 
squalene 27. 
The sequence similarity of SPF to the yeast phosphatidylinositol transfer protein Sec14p 
suggested that phosphatidylinositol might be a ligand for SPF.  Saccharomyces cerevisae 
Sec14p binds phosphatidylinositol (PI) and phosphatidylcholine.  In fact, SPF binds to PI 
with affinity of ~216 nM 27
SPF and Vitamin E 
, which is the greatest reported binding affinity of any ligand 
tested with this protein.  Despite containing the Sec14 domain, the lipid-binding pocket 
of SPF is larger than that of Sec14p.  That leaves a possibility that a larger lipid molecule, 
perhaps one of the phosphorylated forms of phosphatidylinositol, might be a 
physiological ligand for SPF.  
 
 
Using radiolabeled α-tocopherol as ‘bait’, a 46-kD protein was isolated from the cytosol 
of bovine liver in 1999.  It was named α-tocopherol-associated protein (TAP) 28.  As 
noted earlier, subsequently it was found that TAP is identical to SPF 13.  Since then, many 
reports showing the ability of TAP to bind various forms of vitamin E have been 
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published 11; 27; 29-31.  TAP is closely related to α-tocopherol transfer protein (TTP), the 
principal tocopherol binding/transport protein in the cell [ ].  However, in TTP-null mice 
plasma alpha-tocopherol levels are low but levels of liver SPF are not altered, suggesting 
that SPF is not directly involved in α-tocopherol homeostasis 32.  
The term Vitamin E describes a family of tocols and tocotrienols, including α-, β-, γ-, δ- 
tocopherols, which can be distinguished by differently methylated chromanol 
headgroups.  Tocotrienols can also have differently methylated headgroups, but in 
contrast to tocopherols, they have three unsaturated bonds in the phytyl tail.  The only 
naturally occurring stereoisomer of α-tocopherol is RRR- α-tocopherol (2R, 4’R, 8’R- α-
tocopherol).  This is also the most important physiological form of Vitamin E 33.  SPF/TAP 
was reported to bind to tocopherols, tocotrienols and tocoquinones with various 
affinities 27; 29; 31; 33.  Among the tocols, the best binding affinity was reported with γ-
tocopherol, followed by β-tocopherol and α-tocopheryl quinone, an oxidized form of α-
tocopherol 11; 27.  Binding affinity to tocotrienols was not determined.  
Despite numerous efforts, it is still unclear what the physiological ligand for SPF is, a 
characteristic problem for Sec14 proteins.  The possibility exists that all these molecules 
are ligands for SPF under different conditions, or in different cell types, and they may 
also result in different downstream effects 19
tocotrienol
tocopherol
α-tocopherol (R1=CH3, R2=CH3)
β-tocopherol (R1=CH3, R2=H)
γ-tocopherol (R1=H, R2=CH3)
δ-tocopherol (R1=H, R2=H)
.   
 
Figure 1.5: Chemical structures of tocopherols and tocotrienols. 
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Is SPF a transcriptional regulator? 
 
As mentioned above, SPF was purified from bovine liver using α-tocopherol as a bait, 
and there are several reports of SPF binding to vitamin E; whether this link to vitamin E 
is relevant to the stimulatory effect on cholesterol synthesis is unclear 13.  Interestingly, 
in COS-1 cells, SPF moved from the cytosol to the nucleus in response to α-tocopherol 
treatment, and α-tocopherol-dependent transcriptional activation was demonstrated 34, 
raising the question: is SPF a transcription factor?  Indeed, α-tocopherol has been shown 
to regulate the transcription of various genes.  α-Tocopherol downregulates 
transcription of the cholesterol scavenger receptors SR-A and CD36, and upregulates the 
expression of α-TTP protein, and thus may regulate its own homeostasis 13.  In addition, 
α-tocotrienol and γ-tocotrienol were shown to inhibit cholesterol synthesis via post-
transcriptional inhibition of HMG-CoA reductase with γ-tocotrienol being much more 
potent than α-tocotrienol 35.  This effect was later shown to be due to the tocotrienol 
stimulation ubiquitination and degradation of HMG-CoA reductase 36.  A general 
inhibitory effect of α-tocopherol on most cholesterolgenic enzymes was described 
recently 37.  The mechanism of this inhibition was attributed to the modulation of SREBP-
2 processing, preventing the SREBP-2 mature form to reach the nucleus, in a manner 
analogous to that of sterols 36; 37.  In general it appears that actions of α-tocopherol are in 
opposition to those of SPF, which leads to the hypothesis that α-tocopherol binding to 
SPF, if it occurs, might prevent the stimulatory effect of SPF on cholesterol synthesis.  
However, a study from our laboratory failed to demonstrate an effect of α-tocopherol 
on the ability of SPF to stimulate squalene monooxygenase 38, and therefore a link 
between SPF, Vitamin E, and  cholesterol synthesis, if it exists, remains to be elucidated 
13
 
.   
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A role for SPF in cancer 
 
Epidemiologic studies indicated that vitamin E has a protective effect against prostate 
cancer 39. Since SPF was shown to be linked to vitamin E, the effect of SPF on prostate 
cancer was investigated.  Indeed SPF, as α-tocopherol-associated protein (TAP), was 
shown to inhibit the growth of prostate cancer cells in cell culture 40.  Two separate 
mechanisms were identified: First, facilitation of vitamin E uptake and mediation of its 
antiproliferative effect; and second, an effect independent of vitamin E, based on its 
suppression of PI3K/Akt signaling, a major survival pathway in prostate cancer 40.  
Immunohistochemical analysis of tissues from patients that underwent prostatectomy 
showed that expression of SPF was reduced in areas of malignancy compared with 
normal or benign areas.  A significant reverse correlation was also found between SPF 
expression and aggressiveness in malignancy.  Also, a high number of SPF-positive cells 
correlated with a lower incidence of recurrence after surgery.  These interesting findings 
pointed to SPF as a predictor of cancer disease progression and recurrence 41. 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Elzbieta Ilona Stolarczyk 2009 
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Chapter 2 : TISSUE-SPECIFIC EXPRESSION OF THREE HUMAN SPF HOMOLOGS 
 
 
INTRODUCTION 
 
There are three homologous SPF genes in humans: hSPF1, hSPF2 and hSPF3. All three 
genes are located on chromosome 22.  Protein and mRNA identity between these three 
SPFs is shown in Fig. 2.1. 
 
 SPF1/SPF2 SPF1/SPF3 SPF2/SPF3 
mRNA 66 59 61 
Full length protein 77 70 70 
CRAL_TRIO_N domain 
(protein) 
84 80 75 
Sec14 domain (protein) 71 65 63 
GOLD domain (protein) 84 75 84 
 
Figure 2.1: Human SPF and SPF-like proteins.  The table displays the percent identity  
between these three SPFs at the mRNA, protein, and domain level. 
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The best characterized SPF protein to date is SPF1.  Much less is known about the 
expression and function of the two other SPF-like proteins: SPF2 and SPF3.  SPF1 was 
discovered in the liver cytosolic fraction as a factor that stimulated squalene 
monooxygenase 3.  Many years later, when the mRNA sequence of SPF was reported, 
several studies were carried out to determine which tissues express this gene.  It was 
reported that, in addition to liver, SPF transcripts could be detected in small intestine, 
brain, lung and skin 12; however, at that time the additional SPF-like genes had not been 
discovered, and so the possibility of multiple gene transcripts was not addressed.  Later 
studies by another group identified prostate as a site of SPF1 expression 11, and  Kempna 
et al. 31 isolated cDNAs to all three SPF genes from human lung cDNA library and 
reported the expression of all three transcripts in liver, lung, whole blood and skin; 
expression of SPF2 was lowest of the three genes in these tissues.  Later, another group 
confirmed expression of SPF2 in liver, but not in lung 42. Recently, brain and adrenal 
gland were identified as additional sites of all three SPF transcripts presence 43. 
Moreover, SPF3 was found in ovary, testis, epithelial duct cells of several glands and 
endothelial cells of small arteries 43
The reported discrepancies in the tissue-specific expression of the SPF genes may result 
from the use of probes and primers that were not optimized to distinguish between 
these three closely related transcripts.  Given the great degree of similarity between 
these transcripts, special attention should be put into the design of gene-specific probes 
that will detect only the transcript of interest, without crossreacting with transcripts 
from the homologous genes.  To address this need and to unify the expression data for 
all three SPF genes, I designed gene-specific oligos for each SPF transcript, so as to 
optimize the signal detection and specificity and allow analysis of the expression pattern 
of all three genes in multiple tissues concurrently.  Also, for the first time, the relative 
levels of each transcript were to be analyzed in selected tissues so as to gain insight into 
the relative abundance of each SPF transcript.   
. 
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Experimental Rationale 
There are three homologous SPF genes in human.  There were several attempts to 
establish tissue-specific expression pattern for corresponding transcripts 11; 12; 31
MATERIALS AND METHODS 
, however 
I felt they did not exhibit enough precautions to fully differentiate between these highly 
similar transcript sequences.  To address these potential short-comings, the expression 
pattern of three SPF transcripts was assessed with use of highly specific probes designed 
for each SPF transcript.  A broad range of tissues was screened concurrently so as to 
assess the tissue specific expression pattern of each of these genes.  In addition, the 
relative levels of all SPF transcripts in selected tissues was determined by RT-PCR. We 
hypothesize  that  conclusions drawn from this expression data would be useful in 
designing further studies aimed at elucidating the role or roles of the various SPF genes 
in cellular and organismal physiology.   
 
 
Cloning of cDNAs to SPF2 and SPF3 
Amplification: To amplify SPF2 and SPF3 coding sequences, sequence-specific primers 
were designed in such a way that they would incorporate an NdeI restriction site at the 
start codon and an XhoI restriction site immediately before the stop codon. For SPF2 the 
primers were 5’-catatgAGCGGCCGAGTTGGAGAC-3’ and 5’-
ctcgagGACAGGGGTGAGCTCCTTATC-3’ and for SPF3 they were 5’-
catatgAGCAGCCGAGTCGGGGAC-3’ and 5’-ctcgagCTGTGTTGGGGAGGGTCTC-3’. 
Incubation mixtures (50 µl) contained: 1 µg of human lung cDNA library (Clontech), SPF3 
NdeI> and SPF3 XhoI< primers (1 µM each), 2.5 U of Pfu Turbo®DNA polymerase 
(Stratagene), dNTP mix (0.5 mM each), 1x Pfu buffer, and water.  PCR cycling 
parameters were: 5 minutes at 95°C for initial denaturation, followed by 35 cycles of: 
denaturation for 1 minute at 95°C, annealing for 1 minute at 64°C, extension at 72°C for 
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90 seconds, and final extension at 72°C for 10 minutes.  The PCR product was analyzed 
by gel electrophoresis on a 1% agarose gel containing ethidium bromide for DNA 
visualization.   
Subcloning into TOPO: the PCR product was subcloned into Zero Blunt®TOPO® vector 
(Invitrogen).  The TOPO cloning reaction consisted of 4 µl of PCR product, 1 µl of Zero 
Blunt®TOPO® vector, and 1 µl of salt solution (0.2 M NaCl, 0.01 M MgCl₂) combined in a 
small tube and incubated for 7 minutes at room temperature.  For transformation, 1-4 
µl of the TOPO cloning reaction was added to TOP10 chemically competent E.coli cells, 
mixed gently, and incubated on ice for 15-30 minutes.  The cells were heat-shocked for 
45 seconds at 42°C and placed back on ice.  LB media (250 µl) was added to the cells and 
the tube was shaken gently at 37°C for 1 hour.  From 50-200 µl of each transformation 
was spread on a prewarmed selective agar plate (kanamycin for TOPO Blunt) and 
incubated overnight at 37°C.  The next day 6-12 colonies were picked for analysis.  
Analyzing Positive Clones:  Colonies were cultured overnight in LB medium with 
kanamycin.  Plasmid DNA was isolated by miniprep (Promega).  Plasmids were analyzed 
by restriction analysis with restriction sites used for cloning (NdeI, XhoI) or EcoRI.  The 
restriction digestion reaction was performed by mixing 1-2 µg of plasmid DNA with 2 
units of NdeI and 2 units of XhoI in 1xNEBuffer #4 at total volume of 25 µl.  Digestion 
reactions were incubated for 1-3 hours at 37°C and analyzed by gel electrophoresis on 
1% agarose gels to visualize the size of the insert.  The band containing the insert of 
expected size (1200 bp) was cut out of the gel, placed in a 1.5 ml tube with a filter, and 
purified in a microfuge for 5 minutes at 5000 x g.   
Cloning into bacterial expression vector: The pTYB2 vector (New England Biolabs) was 
digested with NdeI and XhoI  restriction enzymes and ligation of the insert into the 
vector was performed as follows.  Purified insert and digested vector were combined 
together with an excess of the insert at a molar ratio of 3:1 in a 20-µl reaction 
containing 0.1-1 U of T4 DNA ligase (Invitrogen) and 1x ligase buffer.  The mixture was 
incubated at room temperature for 1 hour followed by transformation and analysis of 
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positive clones as described above.  Positive clones were sent to a commercial firm 
(Davis Sequencing, Davis, CA) for sequencing.   
Cloning into mammalian expression vector pc3.1DNA(-): The complete coding sequence 
of the SPF3 cDNA was amplified by Pfu polymerase, as described earlier, with the use of 
primers incorporating NdeI and XhoI restriction sites at the N- and C-termini.  The 
reverse primer additionally incorporated a stop codon prior to the XhoI restriction site.  
The amplified sequence was ligated into the Zero Blunt TOPO vector, plasmid DNA 
purified, and the insert was released with NheI and XhoI restriction enzymes.  The insert 
was purified by agarose gel electrophoresis and ligated into pc3.1DNA(-) vector 
(Invitrogen).  Ligation conditions were as described above.  
 
Multiple Tissue cDNA Panels  
Gene-specific primers were selected by visual inspection, comparing the three SPF 
sequences for regions of divergence.  (These primers are shown in Table 2.1.)  For 
optimization the primers were first tested on each of the three SPF cDNAs.  The vectors 
containing these sequences were:  pTYB4SPF1 and pTYB2SPF3 for the full-length SPF1 
and SPF3 cDNAs, and ZeroBluntTOPOSPF2600 for the 600-bp fragment of the SPF2 
cDNA.  Various polymerases and temperature cycling conditions were tested until the 
optimal result was obtained with Taq Polymerase, using a manual ‘hot start’ protocol.  
In this protocol the PCR Master Mix was prepared without Taq Polymerase, the 
reactions were mixed with 5 μl of the cDNA sample in total volume of 50 μl and heated 
to 75°C for 1 minute, and then Taq polymerase was added and thermal cycling started.  
Cycling conditions were: 95°C for 3 minutes, followed by 30 cycles of: 95°C for 45 
seconds, 55°C for 30 seconds, 72°C for 90 seconds, followed by 10 minute extension at 
72°C.  PCR products were then analyzed by gel electrophoresis with staining with 
ethidium bromide. 
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Multiple Tissue Expression Arrays 
The oligonucleotide probes used in this study were selected from the proximal 3’ 
untranslated region of each mRNA.  Each probe was fifty nucleotides long and had three 
biotin moieties at the 5’end.  The sequences of the probes are shown below in Table 
2.3.  Hybridization to the MTE blot was performed according to the manufacturer’s 
instructions (BD Biosciences).  Sheared salmon testis DNA was denatured by heating at 
90-100°C for 5 min, then quickly chilling on ice.  Hybridization solution was prepared by 
mixing BD ExpressHyb Solution (BD Biosciences) with heat-denatured sheared salmon 
testis DNA.  The membrane was prehybridized in hybridization solution with continuous 
agitation for 30 minutes at 42°C.  Each oligonucleotide probe was denatured as 
described above for salmon testis DNA and mixed with hybridization solution, at a final 
concentration of 150 ng/ml.  Hybridization was carried out overnight with continuous 
agitation at the temperature indicated in Table 2.1.  The membrane was washed 5 times 
for 20 minutes with Wash Solution 1 (0.3 M NaCl, 30 mM Na₃Citrate•2H₂O, 1% SDS) at 
the hybridization temperature.  The membrane was incubated with constant agitation 
for 8 minutes in Blocking Buffer (SpotLight™ Hybridization & Detection Kit, BD 
Biosciences), then Streptavidin-HRP conjugate was added and incubated for 15 minutes.  
The membrane was washed 4 times for 2 minutes with 1x Wash Buffer (BD Biosciences, 
Clontech), transferred to another container and incubated for 5 minutes with Substrate 
Equilibration Buffer (BD Biosciences, Clontech), after which the membrane was 
incubated with the mix of Luminol/Enhancer Solution and the Stable Peroxide Solution 
(BD Biosciences, Clontech) for 5 minutes and exposed in the Kodak 1D™ Imager for 30-
60 seconds.  The picture was analyzed with the Kodak 1D™ Imager’s software; dots were 
analyzed as Region of Interest areas (ROIs) and their net intensities were graphed.  Each 
membrane was blotted with one probe only.  The membrane could not be reblotted 
because stripping was not efficient in removing the probe, despite moderating the 
stripping conditions.  
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Table 2.1: Oligonucleotide probes used for hybridization to MTE arrays with their 
hybridization temperatures.  X=biotin. 
Gene Probe 
Hybridization 
temperature 
(°C) 
SPF1 
5’-
TTGACAGGGAGACACTGAGGGGGCCAGGCCTGCTATAGG
AGAAXXXXGG-3’ 
63 
SPF2 
5’-
ACAGAGAAATCAAAGGGTTAGGAGGTCTCTGAGAAATGA
GGGAGXXXXCC 3’ 
60 
SPF3 
5’-
TGAAGGGGTTGGAGTGCACAGGTAGAGGTGGCTGGGGTC
TXXXXTCACT-3’ 
63 
 
RT-PCR analysis of relative expression levels 
Construction of a Standard-Curve Template: For the RT-PCR studies it was necessary to 
construct a template containing the three corresponding cDNA segments of each SPF 
mRNA.  This template would then be used to generate a standard curve for analysis of 
expression of the three SPF genes in each tissue.  Short ~200-bp segments from SPF1 
and SPF3 transcripts were amplified by PCR from a liver single-stranded cDNA library 
created from liver total RNA by reverse transcription.  The primers used to select these 
segments were: 5’-CTCACCTGCAGTGATCCTGGCA-3’ and 5’-GGGGCCAGGCCTGCTATAG-3’ 
for SPF1, 5’-tgtacaATGGGAACCTCACCTG-3’ and 5’-ggtaccTTAGGAGGTCTCTGAGAA-3’ for 
SPF2, 5’-actagtAGCCTCACCTGCCTCCAGG-3’ and 5’-gtaccaGTGCACAGGTAGAGGTGGCTG-
3’ for SPF3.  These 3 cDNA segments were labeled Real1, Real2 and Real3, subcloned 
into the ZeroBluntTOPO or TOPOTA vector and then cloned into pTYB11 vector to serve 
as a template for RT-PCR (see Fig. 2.2, below).  
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Figure 2.2: Cloning scheme for the pTYB11 Real1, Real2, and Real3 templates. 
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Reverse Transcriptase Reaction: First-strand cDNA synthesis was performed using 
SuperScript II Reverse Transcriptase (Invitrogen).  In a nuclease-free tube, 200 ng of 
random primers, 1 ng-5 µg total RNA (Clontech), and 1 µl of dNTP mix (10 mM each) 
were combined in total volume of 12 µl in diethylpyrocarbonate-treated water.  The 
mixture was heated to 65°C for 5 minutes, quickly chilled on ice, briefly centrifuged, and 
4 µl of 5x First-Strand Buffer, 2 µl of 0.1M DTT, 1 µl RNaseOUT (Invitrogen), and 200 
units of SuperScript II Reverse Transcriptase were added.  The reaction was incubated at 
25°C for 10 min, followed by 50 min at 42°C and then inactivated by incubation at 70 °C 
for 15 minutes.  Synthesized single-stranded cDNA (sscDNA) was quantified, aliquoted 
and stored in -80°C. 
Real-Time PCR: Gene-specific primers for real-time PCR were designed by visual 
inspection or by using ABI Prism Primer Express software (Applied Biosystems).  For 
SPF1 they were: 5’-TGCAGTGATCCTGGCATCTATG-3’ and 5’-
TGAGGCTTTGTCTGGAAGCAG-3’, yielding an amplicon of 108 bp; for SPF2: 5’-
TCAGAGGCCGGCGTCTATGT-3’ and 5’-GTGAGCTCCTTATCATATTTCTGCAT-3’ (amplicon of 
129 bp); for SPF3:  5’-AGCCTCACCTGCCTCCAGG-3’ and 5’-CATCGCCTTGAGACTCTGCAG-
3’ (amplicon of 146 bp).  Each 20-µl PCR reaction contained 0.2 μg of single-stranded 
cDNA or template, gene-specific primers (200 nM each), 3 mM MgCl₂, dNTP mix (200 
µM each), 1.25 unit of AmpliTaq Gold (Applied Biosystems), 0.2 units of AmpEraseUNG 
to prevent product carryover, and 1x SYBR Green PCR buffer.  A standard curve was 
created for each pair of gene-specific primers with 10-fold dilutions of template (pTYB11 
Real1, Real2, and Real3).  Cycling conditions were: 2 minutes at 50°C to activate 
AmpEraseUNG, initial denaturation for 10 minutes at 95°C, followed by 40 cycles of: 
denaturation for 15 seconds at 95°C and 1 minute of annealing/extension at 58°C.  In 
order to detect nonspecific amplification, dissociation curves were established for each 
PCR product or PCR products were analyzed by gel electrophoresis. 
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RESULTS AND DISCUSSION 
 
Sequence Alignments 
Measurement of mRNA levels was chosen as the first means for assessing expression of 
the three human SPF genes.  First, the mRNA sequences of three SPFs were aligned with 
use of multiple sequence alignment tool AlignX (VectorNTI, Invitrogen).  This alignment 
revealed the regions of highest similarity and those that were less conserved (Fig. 2.3).  
SPF1 and SPF2 mRNAs were 66% identical, SPF1 and SPF3 mRNAs were 59% identical, 
while SPF2 and SPF3 mRNAs were 61% identical.  
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Figure 2.3: Multiple sequence alignment of the three human SPF mRNAs (sections 1-
52).  NM_012429, human SPF1 mRNA, 2752 bp; NM_174975, human SPF2 mRNA, 2065 
bp; NM_144977, human SPF3 mRNA, 2500 bp.  This multiple sequence alignment was 
created with use of the sequence comparison algorithm AlignX of Vector NTI Advance10 
(Invitrogen).  The SPF gene thought to correspond to the most widely characterized SPF 
is NM_012429.  Sections 11, 13, 14 and 18 are annotated to show the primers used for 
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the Multiple Tissue cDNA Arrays, as described below.  Sections 25 and 26 are annotated 
to show the oligonucleotide probes used for hybridization to Multiple Tissue Expression 
arrays, as described below. 
 
Cloning of SPF2 and SPF3 cDNAs 
The coding sequence for SPF1 was already available in our lab and had been cloned into 
the pTYB4 vector (New England Biolabs, Inc.).  I was unable to amplify the full-length 
cDNA for SPF2 from human liver or small intestine cDNA libraries, despite a variety of 
reaction conditions and multiple primer pairs tested.  Only a ~600 bp fragment (302-882 
bp of the corresponding mRNA) was able to be amplified from a human small intestine 
cDNA  library, and it was subsequently cloned into the Zero Blunt TOPO vector.  
The SPF3 cDNA was amplified from a human lung cDNA library with sequence-specific 
primers derived from the published transcript sequence (NM_174977).  The sequence of 
the polymerase chain reaction (PCR) product was determined and confirmed to be 
identical with SPF3.  This PCR product was cloned into the Zero Blunt TOPO shuttle 
vector (Invitrogen), plasmid DNA was isolated, the insert was released with NdeI and 
XhoI, purified, and cloned into the bacterial expression vector, pTYB2 (New England 
Biolabs, Inc.).  
 
Multiple Tissue cDNA Panels 
The expression of the three SPF genes was first analyzed by PCR using gene-specific 
primers on a set of first-strand cDNAs generated from 8 human tissues (MTC I panel, 
Clontech).  The tissues analyzed were: heart, brain, placenta, lung, liver, skeletal muscle, 
kidney and pancreas.  Gene-specific primers for each sequence were designed and the 
specificity of each primer-pair was tested by PCR on cDNA templates for each SPF cDNA 
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available in the laboratory.  Multiple primer-pairs were tested and the best specificity 
was obtained with the following primers, as shown in Table 2.2.  
 
Table 2.2: Gene-specific primers used in the MTC-PCR experiments. 
 
Gene Primers PCR 
product 
size 
Annotation in 
Fig 2.2 
SPF1 
Fw: 5’-CCACCAGACCACAAAGTTG-3’ 
Rv: 5’-GGCTTTAACAACAAAAAGACG-3’ 
~200 bp 
in red 
in Sections 11&14 
SPF2 
Fw: 5’-CAGAGACCCTGAAGTTCATG-3’ 
Rv: 5’-CACGTACATGGACTTGGGG-3’ ~260 bp 
in green 
in Sections 13/14 
& 18 
SPF3 
Fw: 5’-GTTGCATGAGTGTGAGCTGC-3’ 
Rv: 5’-CAGGTAGTAGCTCTTGGGC-3’ 
~420 bp 
in blue 
in Sections 11&18 
 
   
These primer-pairs were highly specific for their cognate cDNAs, as shown in Fig. 2.4.  
With the confirmed specificity of these gene-specific primers, the expression pattern of 
the three SPF genes in tissues from a Multiple Tissue cDNA panel (MTC) was examined 
(Fig. 2.5).  SPF1 appeared to be expressed in all tissues, as, despite the smear, a band of 
~200bp can be seen in placenta, pancreas, brain, liver and kidney.  A band is less evident 
in lung, heart and muscle, but from this experiment expression cannot be definitively 
ruled out.  Improved PCR results or another approach would be needed to rule out this 
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possibility.  For SPF2 no distinct band of ~260 bp was observed in any tissue.  However, 
the smearing pattern on the gel appears to be different for different tissues and this 
may be due to some nonspecific binding of primers, or there might be some product 
which is not visible due to the smearing.  With SPF3 a clear result indicating no 
expression in any of the tissues, except for pancreas, was obtained.  In general, the 
inability to obtain a clean PCR product in these tissues with these primers prevented the 
unambiguous interpretation of these results, and therefore the outcome of this 
experimental approach was deemed unsatisfactory.  
 
1 2 3 4 1 2 3 4 1 2 3 4
SPF1 primers SPF2 primers SPF3 primers
A B C
 
Figure 2.4: Specificity of the SPF primers.  Gel electrophoresis of the PCR products 
obtained with A, SPF1-specific primers; B, SPF2-specific primers; C, SPF3-specific 
primers.  In each panel the lanes are as follows: lane 1, 500-bp DNA ladder; lane 2, PCR 
product with SPF1 as a template; lane 3, PCR product with SPF2 as a template; lane 4, 
PCR product with SPF3 as a template. 
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Figure 2.5: PCR screen on Multiple Tissue cDNA panels for expression of SPF1, 2 and 3.  
Gel electrophoresis of the PCR products obtained with each set of primers is as follows:  
A, lane 1, 500-bp DNA ladder; lane 2, glyceraldehyde-3-phosphate dehydrogenase 
(G3PDH) PCR product (1000 bp) from control cDNA provided by the manufacturer; lanes 
3-11, PCR products obtained with SPF1 primers on different tissue cDNA templates; 
lanes 12-20, PCR products obtained with SPF2 primers.  The DNA templates are 
indicated above each lane.  B, lane 1, 500-bp DNA ladder; lane2, empty; lanes 3-10, PCR 
products obtained with SPF3 primers on different tissue cDNA templates, as indicated 
above the figure. 
 
Multiple Tissue Expression arrays 
Because of the inconclusive results obtained with the MTC-PCR approach described 
above, hybridization of gene-specific probes to Multiple Tissue Expression (MTE) arrays 
was chosen as an alternative approach to assess tissue expression patterns.  MTE arrays 
consist of a nylon membrane with immobilized polyA+ RNA from 75 different human 
tissues (Table 2.3), allowing the screening of a broad range of tissues in a single 
experiment.  Moreover, the probes for this experiment were designed to the 3’-
untranslated regions of the mRNAs, which share much less identity between SPF genes 
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than do the coding regions.  Therefore, these probes were expected to overcome the 
problems encountered with primer specificity in the earlier MTC-PCR experiments.  The 
probe sequences used in these experiments are indicated in Fig 2.3 in Sections 25 and 
26, and are listed in Table 2.2.  Probes were hybridized to the MTE arrays as described in 
Materials and Methods (see below).  After hybridization the signal from the mRNA dots 
was analyzed and net intensities were determined.  As shown in Figure 2.6, for the SPF1 
transcript the strongest signal was obtained in mammary gland (F9), stomach (B5) and 
liver (A9).  The signal from trachea (H7), prostate (E8) and testis (F8) was weaker but 
noticeable.  There was no distinguishable signal from either SPF2 or SPF3 in this 
experiment (Figures 2.7 and 2.8).  
High expression of SPF1 in liver was not surprising, as it is a main site of cholesterol 
biosynthesis.  Similarly, prostate and testis are also sites of cholesterol and sex hormone 
synthesis.  Moreover, high expression of SPF1 in liver and prostate has been 
demonstrated by others 11.  Mammary gland, especially during lactation, is a site of 
intensive lipid uptake, de novo biosynthesis, transport and excretion; the expression of 
SPF1 in this tissue is consistent with a role for this protein in cholesterol synthesis 
and/or processing.  The basis for expression of SPF in trachea and stomach is less 
evident, but suggests that SPF may have additional functions not yet recognized.  It 
should be noted that polyA+ RNA was prepared from the whole organs without 
distinguishing specific cell-types within the organ, and it is possible that SPF is important 
in particular cell-types within an organ.  Indeed, there are reports demonstrating the 
presence of SPF in endothelial cells of various organs or tissues, consistent with a model 
in which SPF serves as a transporter protein and may be involved in lipid absorption or 
secretion events 43
MTE arrays were normalized to the expression levels of eight different housekeeping 
genes to make possible the quantification of signal and conclusions regarding relative 
transcript abundance in different tissues.  For this reason different amounts of mRNA 
.  Further investigation on cell-type specificity of expression within 
various tissues and cell types will be needed to elucidate such functions.   
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(from 37 to 1127 ng per dot) were loaded on each blot to account for differences in 
transcriptional activity of different tissues (Table in Fig 2.3).  Graphs in Figures 2.6-8 
display net signal intensity obtained from each tissue after hybridization with each 
probe.  The results displayed are one-time measurements, as the probes could not be 
stripped from the blots effectively.  Due to the high cost of each blot, the hybridizations 
were performed only once for each probe.  For this reason the results were not treated 
as quantitative and further conclusions on relative transcript abundance in different 
tissues cannot be made from these data.  Similarly, the results from each blot cannot be 
compared to each other as the blotting was performed at different times with different 
probes and there is no control that would allow for comparison between blots.  
Therefore the relative levels of each transcript in a single tissue cannot be determined 
from these data and another approach had to be undertaken to answer this question. 
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Figure 2.6: Human SPF1 tissue specific expression.  Multiple Tissue Expression (MTE) 
Array probed for presence of SPF1 gene. 
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Figure 2.7: Human SPF2 tissue specific expression.  Multiple Tissue Expression (MTE) 
Array probed for presence of SPF2 gene. 
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Figure 2.8: Human SPF3 tissue specific expression.  Multiple Tissue Expression (MTE) 
Array probed for presence of SPF3 gene. 
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Table 2.3: Positioning and amount of all polyA+ RNAs loaded on Multiple Tissue 
Expression blots. 
 
  Position Tissue ng/dot 
A1 whole brain 130 
B1 cerebral cortex 204 
C1 frontal lobe 124 
D1 parietal lobe 205 
E1 occipital lobe 153 
F1 temporal lobe 205 
G1 postcentral gyrus of cerebral cortex 146 
H1 pons 113 
A2 cerebellum left 227 
B2 cerebellum right 339 
C2 corpus callosum 252 
D2 amygdala 156 
E2 caudate nucleus 216 
F2 hippocampus 170 
G2 medulla oblongata 149 
H2 putamen 175 
A3 substantia nigra 140 
B3 accumbens nucleus 119 
C3 thalamus 142 
D3 pituitary gland 309 
E3 spinal cord 142 
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A4 heart 376 
B4 aorta 77 
C4 atrium, left 253 
D4 atrium, right 190 
E4 ventricle, left 345 
F4 ventricle, right 374 
G4 interventricular septum 506 
H4 apex of the heart 352 
A5 esophagus 100 
B5 stomach 491 
C5 duodenum 161 
D5 jejunum 422 
E5 ileum 190 
F5 ileocecum 176 
G5 appendix 158 
H5 colon, ascending 183 
A6 colon, transverse 130 
B6 colon, descending 124 
C6 rectum 147 
A7 kidney 340 
B7 skeletal muscle 270 
C7 spleen 188 
D7 thymus 146 
E7 peripheral blood leukocyte 185 
F7 lymph node 254 
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H7 trachea 189 
A8 lung 158 
B8 placenta 520 
C8 bladder 183 
D8 uterus 158 
E8 prostate 237 
F8 testis 386 
G8 ovary 153 
A9 liver 1030 
B9 pancreas 1127 
C9 adrenal gland 245 
D9 thyroid gland 188 
E9 salivary gland 548 
F9 mammary gland 101 
A10 promyelotic leukemia, HL-60 39 
B10 Hela S3 95 
C10 K-562, chronic myelogenous leukemia 69 
D10 MOLT-4, lymphoblastic leukemia 42 
E10 Raji, Burkitt's lymphoma 54 
F10 Daudi, Burkitt's lymphoma 37 
G10 SW480, colorectal adenocarcinoma 57 
H10 A549, lung carcinoma 43 
A11 fetal brain 101 
B11 fetal heart  238 
C11 fetal kidney 284 
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D11 fetal liver 237 
E11 fetal spleen 249 
F11 fetal thymus 183 
G11 fetal lung 239 
A12 yeast total RNA  
B12 yeast tRNA  
C12 E.coli rRNA  
D12 E.coli DNA  
E12 Poly r(A)  
F12 human Cot-1 DNA  
G12 human DNA 100 
H12 human DNA 500 
 
 
 
Real-Time Polymerase Chain Reaction (RT-PCR) with the use of a standard curve was 
employed to assess the relative levels of expression of three SPF transcripts in selected 
tissues.  First, the template for the standard curve was created by cloning a short 
segment of each SPF cDNA into the single vector (Fig. 2.9).  A series of template 
dilutions was prepared and the standard curve for each SPF gene was generated (Fig. 
2.10).    
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Figure 2.9: Template for RT-PCR Standard Curve.  A segment of each SPF cDNA was 
cloned into the pTYB11 vector. 
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Figure 2.10: Standard curves generated for each SPF separately from the same 
template.   
 
Gene-specific primers were designed for each transcript and the specificity of these 
primer pairs was confirmed by standard PCR (Fig.2.11).  
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Figure 2.11: Specificity of SPF primers used for RT-PCR.  Gel electrophoresis of the PCR 
products obtained with SPF1-specific primers, SPF2-specific primers, SPF3-specific 
primers on SPF1, SPF2 and SPF3 templates; NTC- no template control (water).  For each 
pair of primers only a band for specific template was obtained, indicating no 
crossreactivity with the other two SPFs. 
The expression of each SPF mRNA transcript relative to the other two SPF transcripts 
was determined with RNA from liver, stomach, and mammary gland; these tissues were 
selected because the MTE blots indicated that all three SPF transcripts were present in 
these tissues.  First, total RNA was reverse-transcribed to a single-stranded cDNA 
template and the expression of each SPF transcript was measured by real-time PCR with 
gene-specific primers.  The quantity of each transcript in these three tissues then was 
determined with use of the standard curve.  As anticipated from the MTE hybridization 
results, the SPF1 transcript was most abundantly expressed in these tissues (Fig. 2.12).   
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Figure 2.12 Relative expression levels of the three SPF transcripts in liver, stomach and 
mammary gland, as determined from the RT-PCR experiments. 
 
In liver, SPF1 mRNA was ~20 fold higher than SPF3 mRNA, followed by very low levels of 
SPF2 mRNA.  Liver was the only tissue where SPF2 mRNA was detectable.  In stomach 
and mammary gland the trend was similar, with SPF1 mRNA levels higher than SPF3 
levels by ~5 fold in stomach and ~70 fold in mammary gland (Fig. 2.11).   
Summarizing, SPF expression was most evident in liver, stomach, and mammary tissue, 
with levels in liver being at least 50-fold higher than those found in other tissues.  My 
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studies further show that, of the three SPF transcripts, SPF1 is the most abundant, 
followed by approximately 20-fold lower expression of SPF3 and negligible expression of 
SPF2.  Although I had hoped to uncover differential expression of these genes in various 
tissues suggestive of functional differences, the expression patterns did not support this 
hypothesis.  In all tissues where SPF was present, SPF1 expression dominated, 
suggesting that SPF2 and SPF3 were either non-functional, of marginal importance, or 
were expressed only in specific conditions or developmental stages.  Further studies will 
be needed to identify any such conditions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Elzbieta Ilona Stolarczyk 2009 
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Chapter 3 :  ABILITY OF THE SPF3 PROTEIN TO STIMULATE CHOLESTEROL SYNTHESIS 
 
 
INTRODUCTION 
 
Homology is defined as similarity between two sequences or structures that is 
attributed to their shared evolutionary history.  There are two types of homologous 
genes: orthologs and paralogs.  Homologous sequences are referred to as orthologs if 
the point of divergence was a speciation event.  Otherwise they are paralogs of one 
another, which is the case for the three human SPF genes.  A common paradigm in 
proteomics is that structure defines function.  Functional assignment is often made 
based on sequence or structural similarity; i.e., if a hypothetical protein is similar in 
sequence or structure to a known protein, it is often provisionally assigned that same 
function.  It is thought that orthologs are more likely than paralogs to retain the same 
function, because the events that give rise to paralogs, such as gene duplication and 
horizontal gene transfer, provide opportunity for diversification of function through the 
relaxation of selective pressure 44; 45
Although it is clear that SPF1 can stimulate squalene monooxygenase in vitro and 
cholesterol synthesis when expressed in cultured hepatoma cells 
.  
 
Experimental Rationale 
12, it is not known if 
SPF2 and SPF3 possess the same stimulatory properties.  Based on the high degree of 
sequence similarity between these gene sequences, I hypothesized that SPF2 and SPF3 
might also stimulate cholesterol synthesis.  However, as noted above, homology does 
not necessarily imply functional equivalence.  Therefore, this hypothesis should be 
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tested experimentally.  To do so I chose microsomal assays and hepatoma cell culture as 
experimental test systems. 
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MATERIALS AND METHODS 
 
Recombinant Protein Expression and Purification 
Recombinant protein was purified with use of the IMPACT (Intein Mediated Purification 
with an Affinity Chitin-binding Tag) protein purification system (New England Biolabs).  
The pTYB2 vector used for cloning is a fusion vector in which the C-terminus of a cloned 
protein is fused to the intein tag followed by chitin binding domain.  The pTYB2 vector 
containing the SPF3 coding sequence (pTYB2 SPF3) was transformed into E.coli ER2566 
competent cells carrying T7 RNA polymerase gene.  Cells were grown at 37°C in 4 liters 
of LB medium containing 100 µg/ml ampicillin.  When the OD₆₀₀ of the culture reached 
0.6-0.8, protein expression was induced with IPTG at a final concentration of 0.5 mM.  
Cells were incubated overnight at constant agitation at room temperature.  On the next 
day the cells were harvested by centrifugation at 5,000 x g for 10 minutes at 4°C.  The 
cell pellet was resuspended in 100 ml of ice-cold Column Buffer (20 mM Tris-HCl, 500 
mM NaCl, 1 mM EDTA, pH 8.0).  Cells were divided into 20-ml portions and lysed by 
sonication on ice with 10-second bursts for a total of 5 minutes.  A cleared lysate was 
obtained by centrifugation at 10,000 x g for 1 hour at 4°C.  To reduce viscosity, lysates 
were treated with DNase for 30 minutes on ice.  Cleared lysates were loaded onto the 
chitin column at 0.5 ml/min at 4°C.  The column was washed with 10 bed-volumes of 
Column Buffer at 2 ml/min. On-column self-cleavage of the chitin-bound intein tag was 
induced by incubating column overnight in Column Buffer containing 50 mM β-
mercaptoethanol and eluting the next day with Column Buffer.  Eluted protein was then 
concentrated, the protein concentration was measured by the Bradford assay and its 
quality and purity was checked by SDS-gel electrophoresis, followed by Coomassie blue 
staining.  Protein was aliquoted and stored at -80°C. 
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Squalene monooxygenase assay 
Preparation of the liver microsomal fraction: Rats were killed by decapitation, the liver 
excised, and microsomes were prepared by standard procedures 21.  In brief, the liver 
was minced thoroughly with scissors, transferred into 2 volumes of ice-cold 
homogenization buffer (100 mM Tris-HCl buffer at pH 7.4, containing 0.1 mM EDTA) and 
homogenized using a Potter-Elveham homogenizer.  All subsequent steps were carried 
out at 4°C.  The samples were centrifuged at 10,000 x g for 20 min, and the pellet was 
discarded and the supernate was centrifuged at 100,000 x g for 60 min.  The upper, lipid 
layer was removed and the cytosolic supernatant fraction collected.  The microsomal 
pellet was resuspended with ice-cold homogenization buffer and recovered by 100,000 x 
g centrifugation for 60 min.  The microsomal fraction was resuspended at ~20 mg of 
protein/ml in homogenization buffer and the cytosolic fraction (100,000 x g supernate) 
diluted to ~20 mg of protein/ml.  The protein content was determined by Bradford assay 
with Coomassie Plus Reagent (Pierce).  Aliquots were 
Squalene Monooxygenase Assay: Microsomal squalene monooxygenase activity was 
determined with rat liver microsomes (400 µg/incubation) in a final volume of 0.2 ml as 
described previously 
stored at -80°C. 
21.  Radiolabeled 14C-squalene was synthesized by SRI International 
(Menlo Park, CA) and used at 7 mCi/mmol.  In brief, 200 µg of microsomal protein, 30 
µM FAD, 40 µM [14C]squalene, 10 µg of phosphatidylglycerol, and 0.3 mM AMO 1618 
(Calbiochem) to inhibit oxidosqualene cyclase in 200 µl of 20 mM Tris-HCl buffer, pH 7.4, 
with 1 mM EDTA.  Reactions were started by the addition of 1 mM of NADPH and placed 
in a 37°C water bath.  After 1 h the incubation volume was brought to 1 ml with water 
and the reactions were stopped by the addition of 0.5 ml of 10% KOH in methanol.  The 
tubes were capped, lipids were saponified at 80 °C for 1 h and then extracted with 3 ml 
of petroleum ether.  The solvent layer was removed by centrifugal evaporation, the 
lipids resuspended in 50 µl of petroleum ether and spotted onto silica thin-layer plates.  
Lipids were fractionated with 5% ethyl acetate in hexane, visualized with iodine vapor 
stain, and quantified by electronic autoradiography (Packard Instant Imager).  The ability 
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of SPF to stimulate squalene monooxygenase was determined by adding 0.8 µg of 
purified recombinant protein, unless indicated otherwise.  Triton X-100 at 0.1% was 
used as a reference for maximal activation of microsomal squalene monooxygenase. 
 
Cell culture 
McARH7777 rat hepatoma cells were cultured in Dulbecco's Modified Eagle Medium 
(Gibco) supplemented with 1x Penicillin-Streptomycin mixture (Invitrogen) and 10% 
Fetal Bovine Serum (Invitrogen).  
 
Transfections 
The day before transfection, cells were plated onto glass coverslips at the density 5x104 
cells per cm2
Cholesterol synthesis assay 
.  On the next day plasmid DNA was transfected into cells with use of 
Fugene 6 (Roche Diagnostics).  Plasmid DNA was mixed with Fugene 6 reagent in serum-
free medium at a ratio of 1 µg:5 µl, and complexes were allowed to form for 30 min at 
room temperature.  The medium on the cells was replaced with antibiotic-free medium 
with 10% FBS and the transfection mixture was added dropwise to the cells.  Cells were 
assayed 48 hours post-transfection. 
 
Cholesterol synthesis was measured 48 hours post transfection as follows.  The media 
was replaced and 14C-acetate at 1 µCi/35 mm well was added and cells were incubated 
for 3 hours at 37°C.  The media was removed, the cells were washed with PBS, and 1 ml 
of water was added and the cells were released by scraping.  Cells were lysed by 
sonication in a water bath for 1 minute, after which 3 ml of a chloroform:methanol (2:1) 
mixture was added to each tube and the mixture was vortexed vigorously 5-10 times.  
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The lower fraction containing lipids was transferred into a new tube and the solvent was 
evaporated under liquid nitrogen.  Samples were resuspended in 50 µl of a chloroform: 
methanol mixture and spotted onto silica thin-layer plates.  Lipids were fractionated 
with petroleum ether:ethyl ether:acetic acid (60:40:1), cholesterol was identified by co-
chromatography of authentic standard visualized by iodine-vapor staining, and 
quantified by electronic autoradiography (Packard Instant Imager).  
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RESULTS AND DISCUSSION 
 
Expression and purification of human recombinant SPF1 and SPF3 proteins 
Following the cloning of SPF3 into pTYB2 vector, as described in Chapter 2, the SPF1 and 
SPF3 proteins were expressed in E.coli strain ER2566 and purified following the protocol 
for intein-fusion proteins with the IMPACT system (New England Biolabs, Inc.).  Because 
a full-length SPF2 cDNA could not be cloned, it was not possible to generate and test 
this putative protein.  The pTYB vectors are designed specifically for purification with the 
IMPACT system, which attaches a self-splicing element (intein) followed by a chitin 
binding domain to the carboxy-terminus of the expressed protein, which allows for 
binding to a chitin affinity column.  The expressed protein is then released with β-
mercaptoethanol, which promotes intein self-splicing and release of protein.  The 
cleaved, purified protein retains four extra amino acids at the C-terminus: Leu-Glu-Pro-
Gly.  The concentration of recombinant proteins was measured with use of the BCA 
protein assay (Pierce) and the purity was analyzed by SDS electrophoresis followed by 
Coomassie Blue staining (Fig. 3.1).  
 
Figure 3.1: SDS-gel electrophoresis of recombinant SPF1 and SPF3 proteins. 
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Stimulation of squalene monooxygenase activity by SPF3 
The ability of the recombinant human SPF1 protein to stimulate squalene 
monooxygenase activity by  approximately 2-fold in microsomes has been reported 21. 
Maximal stimulation was achieved with 0.8 μg of recombinant protein in a 200-μl 
incubation, while higher concentrations were inhibitory 8; 21; 46.  Therefore, a range of 
concentrations was tested with the SPF3 recombinant protein (Fig. 3.2).  Triton X-100, 
which is strongly stimulatory to this enzyme in vitro, was included as a positive control.  
Consistent with previous reports, recombinant SPF1 protein stimulated the activity of 
squalene monooxygenase by ~2 fold.  Statistical analysis by one-way ANOVA showed 
that this stimulation is statistically significant (p < 0.05).  In contrast, SPF3 protein was 
unable to stimulate squalene monooxygenase activity across the range of 
concentrations tested.  This raises the possibility that the recombinant SPF3 protein has 
other functions or needs other conditions, or cofactors not supplied in microsomal assay 
to stimulate squalene monooxygenase.  To address this possibility, the ability of SPF3 to 
increase cholesterol synthesis in mammalian cell culture was tested. 
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Figure 3.2: Squalene monooxygenase activity in the presence of recombinant SPF1 and 
SPF3.  Radiolabeled 2,3-oxidosqualene formation from squalene was visualized and 
measured by electronic autoradiography (Packard Instant Imager).  A) Radiolabeled 2,3-
oxidosqualene visualized on a thin-layer chromatography (TLC) plate.  B) Quantitative 
analysis of radiolabeled 2,3-oxidosqualene formation. 
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Stimulation of cholesterol synthesis in rat hepatoma cells 
 
Cloning 
In order to express the SPF3 protein in rat hepatoma cells, its cDNA had to be cloned 
into the mammalian expression vector pc3.1DNA(-) (Invitrogen).  [The SPF1 cDNA had 
been cloned into this vector earlier 23
Characterization of an antibody for quantitation of SPF3 
]  The full-length SPF3 coding sequence was 
amplified from pTYB2SPF3 vector with the use of primers incorporating NdeI and XhoI 
restriction sites at the termini.  The reverse primer incorporated a stop codon prior to 
the restriction site.  The amplified sequence was ligated into the Zero Blunt TOPO 
vector, plasmid DNA purified, and the insert released with NheI and XhoI restriction 
enzymes.  The insert was then purified and ligated into the mammalian expression 
vector pc3.1DNA(-) vector.   
 
To assess expression levels of SPF1 and SPF3 proteins after transfection into the 
hepatoma cells, an antibody detecting both proteins was needed.  Rabbit polyclonal 
hSec14l2 antibody (GenWay) was previously tested on immunoblots and in 
immunofluorescence and showed a very good signal and the ability to detect the 
human, rat and mouse SPF proteins.  To address the question of whether this SPF1 
antibody also recognizes the SPF3 protein, 50-250 ng of each protein was fractionated 
by SDS-polyacrylamide gel electrophoresis, followed by electrophoretic transfer for 
immunoblotting.  Band intensities were measured and plotted against the protein 
amount.  It was found that rabbit hSec14l2 antibody (GenWay) detects both SPF1 and 
SPF3, although it has approximately 3-fold better sensitivity for SPF1 (Fig. 3.3). 
 
63 
 
 
Figure 3.3: Detection of SPF1 and SPF3 proteins with rabbit Sec14l2 antibody.  A) 
Immunoblot of SPF1 and SPF3 recombinant proteins probed with rabbit polyclonal 
Sec14l2 antibody (GenWay, Inc).  B) Semi-quantitative analysis of immunoblot. 
 
 
HA epitope cloning 
To achieve more comparable results, site-directed mutagenesis was employed to insert 
an hemagglutinin (HA) epitope at the C-terminus of SPF1 and SPF3 (this cloning 
procedure is described in Chapter 4).  In subsequent experiments, rabbit polyclonal HA-
probe (Y11) antibody (Santa Cruz Biotechnology, Inc.) was used to compare protein 
expression levels. 
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Cholesterol synthesis assay with SPF1 and SPF3 
Rat hepatoma cells were transfected with SPF1, SPF3, or vector plasmid with Fugene6 
transfection reagent (Roche) on day 0.  On day 2 de novo cholesterol synthesis from 14
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acetate was measured in a 3 h window.  Results from 3 separate experiments are shown 
below (Fig. 3.4). 
 
Figure 3.4: Stimulation of cholesterol synthesis in rat hepatoma cells upon transfection 
with SPF1/3 expression plasmids.  White bars: control (lacZ-transfected cells); red bars, 
SPF1-transfected cells; blue bars, SPF3-transfected cells.  Each value represents the 
mean ± S.E. of one experiment carried out in triplicate.  Statistical analysis was 
performed with one-way ANOVA followed by Tukey’s Multiple Comparison Test; a single 
asterisk (*) indicates a significant difference from the control with p<0.05; a double 
asterisk (**) indicates a p value <0.01. 
 
As can be seen from this set of experiments, SPF3 was just as effective as SPF1 in 
stimulating cholesterol synthesis in transfected hepatoma cells.  This result is in contrast 
to the lack of stimulation obtained with SPF3 in microsomal squalene monooxygenase 
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assays (Fig. 3.2).  To ensure that SPF3 expression in these cells was comparable to that 
of SPF1 in SPF1-transfected cells, mRNA and protein levels were determined in cells 
transfected with each plasmid.  As shown in Fig. 3.5, mRNA and protein expression 
levels varied significantly between experiments, probably reflecting transfection 
efficiency.  Within an experiment generally similar levels of expression were obtained 
for both proteins, suggesting that SPF1 and SPF3 proteins have similar 
synthesis/degradation profiles.  Moreover, protein levels correlated reasonably well 
with mRNA levels within each experiment for each expression construct, again 
suggesting that the differences in protein levels between experiments largely reflected 
transfection efficiency rather than differences in transcription, translation, or mRNA or 
protein stability for either protein.   
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Figure 3.5: Expression levels of SPF1 and SPF3 in transfected rat hepatoma cells.  Data 
are taken from three separate experiments.  A) RNA levels assessed by RT-PCR; B) 
protein levels as determined from semiquantitative analysis of immunoblot images 
(shown below the graph).  Proteins were probed with an antibody against the HA 
epitope (Y11); β actin was probed with a mouse anti β-actin antibody.  Intensities of the 
bands were quantified with use of ImageJ software (NIH, MD) and expressed as the ratio 
of HA tag signal/β actin.  C) Correlation of RNA and protein levels. 
 
To assess the transfection efficiency of these plasmids, immunofluorescent staining of 
transfected cells was employed, using an antibody that recognizes the added HA 
epitope of each protein.  Representative pictures are shown in Fig. 3.6.  In these 
experiments transfection efficiencies were uniformly low (< 10%), but did not differ 
greatly between experiments or between plasmids.  Moreover, the intensity of the 
staining did not differ between the plasmids, suggesting that both proteins were equally 
well expressed in these cells.  In experiment #1 roughly ~1% of cells expressed SPF1 and 
~3% expressed SPF3; in experiment #2 ~4% cells expressed SPF1 and ~8% expressed 
SPF3; in experiment #3 ~1% of cells expressed SPF1 and ~6% expressed SPF3.  In 
general, higher transfection efficiencies yielded higher mRNA and protein expression 
levels, and largely correlated with the expression the corresponding SPF protein:  
Experiment 2 showed relatively high transfection efficiency for both plasmids, and the 
highest protein and mRNA levels as assessed by immunoblotting and RT-PCR, 
respectively; Experiment 3 showed the greatest difference in transfection efficiency 
between the two plasmids, and also the greatest difference in SPF protein expression 
levels.   
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Figure 3.6: Transfection efficiency of SPF1 and SPF3 expression plasmids as 
determined by immunofluorescent staining.  Red, HA tag; blue, DAPI nuclear stain.  
Representative pictures from three separate experiments.  In experiment #1 ~1% of 
cells expressed SPF1 and ~3% expressed SPF3; in experiment #2 ~4% cells expressed 
SPF1 and ~8% expressed SPF3; in experiment #3 ~1% of cells expressed SPF1 and ~6% 
expressed SPF3. 
 
When the ability to stimulate cholesterol synthesis (data from Fig. 3.4) is expressed 
relative to the level of expression of each SPF protein (data from Fig. 3.5), the “specific 
activity” of each SPF can be determined, as shown in Fig. 3.7.  From this analysis it 
appears that SPF1 is slightly more effective that SPF3 in its ability to activate this 
pathway, although the difference is not statistically significant.   
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Figure 3.7: Specific activity of SPF1 and SPF3 proteins to stimulate cholesterol 
synthesis.  A) Data from three separate experiments; activity of SPF1 protein in each 
experiment was set as 100% in order to enable comparison with SPF3 “specific” activity 
B) Average of the same data. 
Several conclusions can be drawn from this data.  The ability of SPF proteins to stimulate 
cholesterol synthesis appears quite robust; this conclusion is based on the 1.5- to 2-fold 
increase in radiolabel incorporation into cholesterol in cultures in which less than 10% of 
the cells are transfected with an expression plasmid.  This suggests that the rate of 
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cholesterol synthesis in transfected cells is as much as 10-fold higher than that in 
untransfected cells.  Secondly, the ability of SPF3 to stimulate cholesterol synthesis 
appears not to be dependent on a stimulation of squalene monooxygenase activity, as 
the recombinant protein was largely inactive in microsomal assays of squalene 
monooxygenase activity (Fig. 3.2).  This is in marked contrast to SPF1, which is able to 
double the activity of this enzyme.  This suggests that SPF3 acts at a second site in the 
cholesterolgenic pathway, likely HMG-CoA reductase, the well-recognized regulatory 
step in cholesterol synthesis.  It has been shown by this laboratory that SPF1 increases 
the activity of this enzyme in cell culture and in vitro 23.  Because HMG-CoA reductase is 
typically the rate-limiting step in cholesterol synthesis, stimulation of this activity is 
almost certainly necessary to increase the overall rate of cholesterol synthesis in whole 
cells, with stimulation of squalene monooxygenase playing a secondary role.  Thus, 
although SPF3 does not stimulate squalene monooxygenase activity, it may increase 
cholesterol synthesis by acting at HMG-CoA reductase to increase the overall activity of 
this pathway.   
Finally, it is worth noting that SPF3 expression is approximately 20-fold lower than SPF1 
in liver, based on the expression data presented in Chapter 2.  Thus, in this highly 
cholesterolgenic tissue SPF3 is not likely to play a significant role.  It may assume greater 
importance in other tissues, such as stomach or mammary gland, or during 
development. 
 
 
 
 
Copyright © Elzbieta Ilona Stolarczyk 2009 
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Chapter 4 : INTRACELLULAR LOCALIZATION OF HUMAN SPF PROTEIN 
 
 
INTRODUCTION 
 
Supernatant Protein Factor (SPF) was originally purified from rat liver cytosol 6
In African green monkey kidney (Cos-7) cells, heterologously expressed SPF protein 
translocated into the nucleus upon the addition of α-tocopherol 
, and 
could not be detected in the microsomal fraction.  Comparison to the database of 
known proteins revealed that SPF possesses a lipid binding domain (termed Sec14), and 
Golgi dynamics (GOLD) domain.  This suggests that SPF might be an intracellular lipid 
transport protein and that it may interact with membrane components upon ligand 
binding or in response to certain stimuli.  
34.  It was further shown 
by luciferase reporter assay that SPF, upon addition of α-tocopherol to the cells, acts as 
a transcription factor 34.  However, in cervical carcinoma (Hela) and mouse mast cells, 
heterologously expressed SPF protein localized to the cytosol and failed to move to the 
nucleus in response to α-tocopherol 31; 47
Recent studies by Zingg et al. 
. 
43 have demonstrated that in mastocytoma (HMC-1) and 
lung carcinoma (A549) cells, endogenous SPF1 protein partially co-localized with the 
Golgi protein giantin. In Hela and adrenocortical (H295R) cells SPF co-localized with a 
mitochondrial marker.  Localization of SPF1 to the Golgi suggested a role in this 
secretory pathway, while association with mitochondria was suggested to have specific 
function in the transport of lipid molecules (vitamin E, squalene, phospholipids) into and 
out of mitochondria 43. All these reports suggest that SPF localization events are cell-
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type specific and may have different roles depending on cell type, ligand, or specific 
conditions. 
Incubation of microsomes with the cytosolic fraction or recombinant SPF protein results 
in an increase of squalene monooxygenase activity.  This effect was potentiated by 
addition of ATP to the cytosol, which suggested that secondary modification by 
phosphorylation may be necessary for full SPF activity 21.  In support of this suggestion, 
addition of certain kinase inhibitors blocked the ATP-induced increase in SPF activity, at 
the same time narrowing the pool of kinases to protein kinase A (PKA) and C (PKC).  A 
decrease in cytosolic SPF activity was also observed upon addition of various protein 
phosphatases, which were able to reduce SPF activity by ~50%.  To extend these studies, 
recombinant SPF protein was preincubated with PKA or PKC in the presence of ATP prior 
to addition to the squalene monooxygenase assay.  In both cases there was ~2 fold 
increase in SPF activity 21.  The conclusion drawn from these studies was that SPF is 
activated by PKA and PKCδ by phosphorylation on one or more serine or threonine 
residues.  The SPF sequence contains three consensus sequences for PKA and six for 
PKC.  It was later found that rat SPF2 is also stimulated by PKA 38.  Sequence alignment 
of rat and human SPF proteins revealed a single conserved PKA consensus site; 
substitution of a serine in this consensus site with alanine resulted in a mutated protein 
(SPF1S289A) which retained basal SPF activity in the microsomal assay but could no 
longer be activated by PKA or C.  These in vitro results were later confirmed in a cell 
culture system 23
 
.  Cholesterol synthesis was elevated in rat hepatoma cells upon 
transfection with SPF and it was further increased when dibutyryl-cAMP, a PKA 
activator, was added.  Total loss of SPF stimulation was observed upon addition of a cell 
permeable PKA inhibitor, 14-22 amide.  Morover, expression of the phosphorylation 
mutant (SPF1S289A) failed to result in stimulation of cholesterol synthesis in hepatoma 
cells, indicating that this serine residue (S289) has to be phosphorylated to stimulate 
cholesterol synthesis in whole cells. 
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Since GOLD domain stands for Golgi Dynamics domain, and the GOLD domain is thought 
to be involved in protein-protein interactions and intramembrane events, it was 
suggested that SPF associates with Golgi.  One of the means to test this hypothesis was 
the construction of a GOLD domain deletion mutant (SPF1del111/SPF292).  This 
truncated protein was expressed in rat hepatoma cells and indeed, was unable to 
stimulate cholesterol synthesis in these cells.  This result revealed that the GOLD domain 
is necessary for the SPF stimulatory effect and suggested that interaction with Golgi may 
be required for SPF function.  To determine if interaction with Golgi is required for 
stimulation of cholesterol synthesis by SPF1, studies with brefeldin A, which disrupts 
Golgi structures, were carried out 22.  The stimulatory effect on cholesterol synthesis in 
SPF1-overexpressing cells was totally lost in brefeldin A-treated cells, which could be 
reversed by removal of the disaggregator, allowing reassembly of the Golgi bodies.  
These results indicated that SPF-mediated stimulation of cholesterol synthesis depends 
on intact Golgi and phosphorylation of SPF 22
SPF is presumably a transporter protein and therefore I hypothesized that in response to 
ligand binding or/and other stimuli it would redistribute within the cell. Two SPF 
mutants, one having serine 289 replaced by alanine, and the other missing the GOLD 
domain, are inactive, and therefore I hypothesized that, in contrast to the wild type 
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Experimental Rationale 
SPF proteins belong to a family of lipid binding proteins and are thought to be involved 
in intracellular transport of small lipid molecules. The structure contains lipid binding 
domain and GOLD domain that is thought to be involved in bringing cargo from ER 
towards Golgi or in other protein-protein interactions.  Previous studies have shown 
that the SPF1 protein is activated by phosphorylation and that Ser289 is required for this 
phosphorylation.  Also, stimulatory the effect of SPF on cholesterol synthesis requires 
intact Golgi and the GOLD domain is thought to mediate this putative interaction.  
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protein, these mutant SPF proteins would fail to localize correctly in the cell during 
cholesterol synthesis or upon phosphorylation.   
To test this hypothesis, immunolocalization studies on hepatoma cells transfected with 
an SPF expression plasmid or SPF mutants.  Transfected cells were treated with 
inhibitory and activating stimuli which were shown earlier to affect SPF activity 
(dbcAMP, brefeldin A, PKAi, Vitamin E).  Since these treatments and alterations have a 
significant effect on the ability of SPF to stimulate cholesterol synthesis, I hypothesized 
that they will also engender changes in SPF localization inside the cell.  Identification of 
the subcellular compartments to which SPF localizes in response to these treatments 
would provide insight on the mechanism of SPF function.  
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MATERIALS AND METHODS 
 
Site directed mutagenesis by overlap-extension PCR 
The PCR fragment (A-Mut-B) containing the desired mutation was obtained in a 
sequence of reactions depicted on the scheme in Fig. 4.1 and was used in the whole 
plasmid amplification reaction (WPA).  A 50 μl WPA reaction consisted of: 50 ng of 
template DNA (purified plasmid containing gene to be mutated, in this case pc3.1SPF1), 
a primer pair (1 μl of A-Mut-B PCR fragment), 0.2 mM dNTPs, 1x Pfu buffer, and 2.5 U of 
Pfu Turbo DNA polymerase.  Reaction conditions were: 95°C for 1 minute, followed by 
18 cycles of: 95°C for 1 minute, 55°C for 1.5 minutes, and ending with 68°C for 9 
minutes.  
 
Cell culture   
McARH7777 rat hepatoma cells were cultured in Dulbecco's Modified Eagle Medium 
(Gibco) supplemented with 1x Penicillin-Streptomycin mixture (Invitrogen) and 10% 
Fetal Bovine Serum (Invitrogen). 
 
Plasmid transfections 
The day before transfection, cells were plated on glass coverslips at a density of 5x104 
cells per cm2.  On the second day plasmid DNA was transfected into the cells with use of 
Lipofectamine™ (Invitrogen) or Fugene6 (Roche Diagnostics).  Lipofectamine 
transfections: Plasmid DNA was pre-complexed with Plus™ Reagent (Invitrogen) in 
serum-free medium at the ratio 1 µg:10 µl and incubated at room temp for 15 min.  
Medium-diluted Lipofectamine was added (2.5 µl per 1 µg of DNA) to form complexes 
with the mixture and incubated at room temperature for 15 min.  The media was 
replaced with half of the recommended volume of serum and antibiotic-free DMEM 
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medium.  The transfection mixture was added dropwise to the cells and they were 
allowed to incubate at 37°C.  After 3 h the volume of medium was increased to normal 
volume with DMEM containing 20% FBS and 2% penicillin/streptomycin solution.  
Fugene6 transfections: Plasmid DNA was mixed with Fugene 6 reagent in serum-free 
medium at the ratio 1 µg:5 µl and complexes were allowed to form for 30 min at room 
temperature.  The media was replaced with antibiotic-free medium containing 10% FBS 
and the transfection mixture was added dropwise to the cells. 
 
Immunofluorescence 
To determine the cellular localization of the expressed SPF protein, cells were stained 
with primary antibody against the hemagglutinin epitope (rabbit polyclonal HA-probe 
Y11) followed by a secondary antibody conjugated to the fluorophore, which, upon 
excitation, emits fluorescence with a maximum at the specified wavelength.  For 
colocalization studies antibodies for organelle-specific proteins were used.  Cells, once 
immunostained and mounted on the glass slides, were analyzed by confocal microscopy.  
Efficiency of transfection was also confirmed through X-gal staining on cells transfected 
with plasmid containing the lacZ gene. 
 
Isolation of primary hepatocytes 
Hepatocytes were prepared from mice as follows: mice were anesthetized with 
Ketamine and the liver was perfused via the portal vein with 30 ml of liver perfusion 
solution (Ca²+ and Mg²+-free HBBS, 10 mM HEPES, pH 7.4, 0.1 mg/ml gentamycin sulfate, 
and 0.5 mM EGTA) followed by 30 ml of collagenase solution (Ca²+ Mg²+-free HBBS, 
0.06% collagenase, supplemented immediately before use with CaCl2, to final 
concentration of 0.5 mM) at 3ml/min.  The liver was removed, transferred into a tissue 
culture plate with collagenase solution and the liver capsule was removed, the 
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hepatocytes were dissociated by shaking and filtered through a double layer of gauze.  
The cells were pelleted at low speed in a microcentrifuge, washed twice, counted, and 
viability determined by trypan blue exclusion.  Hepatocytes were plated on coverslips 
coated with collagen in 35 mm dishes at 0.5 x 106
 
 cells per 1 ml in DMEM containing 5% 
FBS.  After 3 hr, the cells were washed and the medium was replaced with fresh 
medium.  On the following day the hepatocytes were stained for immunofluorescent 
analysis. 
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RESULTS AND DISCUSSION 
 
Site-directed mutagenesis of SPF  
The coding sequence for the hemaglutinin (HA) epitope (YPYDVPDYA) was inserted at 
the carboxy termini of the SPF cDNAs previously cloned into the pc3.1DNA(-) plasmid 
(SPF1, SPF1 mutants and SPF3).  Insertion of the HA tags was carried out with site-
directed mutagenesis by overlap extension PCR, using the strategy depicted on the 
scheme below (Fig. 4.1).  In brief, two fragments of a target sequence are amplified in 
two separate PCR reactions (A and B) by using, for each reaction, one universal (A or B) 
and one mutagenic primer, which contains desired insertion, deletion or point mutation 
(A-Mut, B-Mut).  The two PCR products of these reactions were complementary at one 
end and they served as a new, overlapping template for the next reaction.  DNA 
amplification on the overlapping template was performed with only the universal 
primers (A and B).  The overlapped PCR product containing the desired mutation (A-
Mut-B) was used as a primer pair for whole plasmid amplification of the original 
template.  The product of this amplification contains mutated DNA; to eliminate the 
unmutated, original DNA template, digestion with the restriction enzyme DpnI was 
performed, taking advantage of its ability to cleave only methylated DNA.  
Unmethylated, mutated plasmid was used to transform competent cells.  These cells 
were then grown on selective media, DNA isolated and sent for sequencing to identify 
positive clones.  As a result, the following constructs were obtained: pc3.1SPF1-HA, 
pc3.1SPF1S289A-HA, pc3.1SPF1del111-HA, and pc3.1SPF3-HA. 
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Figure 4.1: Scheme for insertion of the HA tag into the SPF plasmids.   
 
Cellular localization of heterologously expressed SPF protein 
Rat hepatoma cells (McARH7777) were grown in 6-well plates and on glass coverslips 
and pc3.1SPF1-HA cDNA was transfected into the cells with use Fugene 6 Reagent 
(Roche).  On the second day post-transfection, the expression of SPF protein was 
confirmed by immunoblotting using an antibody to the HA epitope, as follows.  The cells 
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grown on coverslips were fixed with ice-cold methanol and processed for 
immunofluorescence.  Coverslips were incubated with primary antibody against the HA 
tag or against a marker of interest.  To detect the signal, a secondary antibody 
conjugated to fluorochrome was used.  The coverslips were mounted on glass slides and 
analyzed by fluorescent or confocal microscopy.  Expressed SPF appeared to localize to 
the cytosol (Fig.4.2). 
 
Figure 4.2: SPF1-HA protein expressed in McARH7777 cells.  A) HA probe (red); B) 
Grp94 marker for endoplasmic reticulum (green); C) DAPI nuclear stain (blue); D) merge 
of A, B and C. 
 
To determine whether the heterologously expressed SPF protein changes its 
intracellular location in response to phosphorylation, transfected cells were treated with 
dbcAMP, a PKA stimulator, or 14,22-amide, a PKA inhibitor.  No change in localization 
was observed upon either of these treatments (Fig. 4.3 E-H). 
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Since disruption of Golgi resulted in loss of the SPF-mediated stimulatory effect on 
cholesterol synthesis 22, SPF-transfected cells were treated with brefeldin A for 3 hours 
prior to immunostaining.  Disruption of Golgi was confirmed by immunostaining for the 
Golgi marker GM130 protein (Fig. 4.3 J).  No change in SPF subcellular localization was 
observed upon disruption of Golgi (Fig 4.3 I-L).  Upon treatment with α-tocopherol SPF 
protein was reported to translocate from cytosol into the nucleus in Cos-7 cells 34.  In 
transfected rat hepatoma cells SPF protein appeared to remain in cytosol upon addition 
of α-tocopherol (data not shown).  
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Figure 4.3: SPF1-HA protein expressed in McARH7777 cells, treated with dbcAMP and 
brefeldin A.  Green - HA probe; red - Golgi marker (GM130); blue - DAPI nuclear stain. 
 
Immunolocalization studies with mutant SPF proteins, previously shown to lose the 
ability to stimulate cholesterol synthesis, were then performed.  Phosphorylation 
mutant (SPF1S289A) and GOLD domain deletion mutant (SPF1del111) were expressed in 
rat hepatoma and cells processed for immunofluorescence.  Compared with wild-type 
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protein, no difference was observed in the subcellular localization of SPF1S289A mutant, 
as it remained in the cytosol (Fig 4.4 E-H).  Interestingly, the Golgi domain deletion 
mutant, SPF1del111, localized to large vesicular formations around the nucleus, but 
which appear to be different from Golgi (Fig 4.4 I-L).  A similar result was found for the 
protein-tyrosine phosphatase PTP-MEG2, in which a deletion mutant consisting of the 
Sec14 domain of this protein also associated with large vesicular structures surrounding 
the nucleus 15.  This raises the possibility that the GOLD domain is not the only targeting 
signal on SPF, and that the Sec14 domain, assumed to be involved only in lipid binding, 
also contributes to the subcellular localization of these proteins.  In support of this 
hypothesis, p45, the rat ortholog of SPF2, associates with large cytoplasmic vesicles, and 
this association is not disrupted by removal of the GOLD domain 48.  Together these 
findings suggest that SPF targeting in the cell is a complex function of multiple 
components of this multidomain protein. 
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Figure 4.4: SPF1 and it mutants expressed in McARH7777 cells.  Green - HA probe; red - 
Golgi marker (GM130); blue - DAPI nuclear stain. 
 
As mentioned earlier and shown in Fig. 4.3, heterologously expressed SPF protein 
localized to the cytosol and did not appear to move in response to any of tested 
treatments.  Because expression from the transfected plasmid yields higher than normal 
levels of the protein in the cell, subcellular movement in response to various stimuli may 
not be evident, as the abundance of the protein may obscure the relocation of a small 
but important fraction of the protein.  It is also possible that the very high levels of 
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expressed SPF protein overwhelm the cellular processing machinery, such as the 
phosphorylation pathway, resulting in a majority of protein that is not properly modified 
for activity.  To address this possibility, I attempted to see where the endogenous SPF 
localizes.  Unfortunately, McARH7777 cells express negligible amounts of SPF, which is 
undetectable by immunofluorescence with antibodies to SPF.  Therefore, to assess 
localization of endogenous SPF the studies were carried out with mouse primary 
hepatocytes. 
 
Antibody specific for SPF protein 
Our custom-made chicken antibody against SPF was successfully used for 
immunoblotting, however the results from immunofluorescence studies were 
unsatisfactory.  Various methods of fixation (4% paraformaldehyde, ice-cold methanol) 
and blocking (BSA, goat serum) were tested, as well as range of antibody 
concentrations.  Despite these efforts, the background signal remained very high.  The 
most likely reason for this appeared to be the purity of the antibody.  Therefore, the 
antibody was purified by affinity chromatography. 
Affinity chromatography takes advantage of specific binding between interacting 
molecules.  The system for chromatographic purification is composed of a column with 
an immobilized ligand through which the mixture to be purified is passed.  Only 
molecules having specific binding affinity to the ligand stay on the column and are later 
eluted.  The appropriate ligand for antibody purification in this instance is SPF, and so 
large quantities of recombinant SPF1 are needed.  As the previously purified protein 
exhibited some contamination when evaluated by SDS-polyacrylamide gel 
electrophoresis, the protein was further purified by gel filtration.  Gel filtration, also 
called size-exclusion chromatography, separates molecules based on size.  Multiple 
fractions were collected, analyzed by electrophoresis, and those containing only the 46-
kD protein were pooled, resulting in significantly improved purity of the SPF1 
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preparation.  For affinity chromatography the recombinant SPF protein was immobilized 
to a SulfoLink (SulfoLink, Pierce) column, taking advantage of free sulfhydryl bonds 
(cysteines) on SPF.  The chicken SPF primary antibody was applied to the column, 
washed with several volumes of buffer, and eluted with a low pH glycine buffer and 
subsequently neutralized by addition of 1M Tris-HCl, pH 8.5, before use. 
Affinity-purified chicken SPF antibody was tested by immunostaining of SPF-transfected 
cells.  There was a marked increase in signal from transfected cells compared with signal 
obtained with non-purified antibody, however the background remained high in cells 
that did not express the transfected protein, and therefore unsatisfactory (Fig. 4.5). 
 
Figure 4.5: Affinity-purified chicken SPF antibody shows significant background in 
immunofluorescent staining.  Hepatoma cells transfected with SPF1-HA protein and 
stained with: A, affinity-purified chicken SPF antibody; B, HA probe; C, DAPI nuclear 
stain; and D, merge of A-C. 
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Subsequently new commercial antibodies to SPF became available.  I tested goat 
polyclonal SPFα/β(N-18) and SPFα/β(N-14) antibodies (Santa Cruz Biotechnology, Inc.); 
however, they showed a very weak and not very specific signal on immunoblots.  
Fortunately, rabbit anti-human Sec14l2 antibody (GenWay Biotech, Inc.) yielded a 
strong and very specific signal on immunoblots as well as in immunofluorescent 
staining. 
Before isolation of primary hepatocytes the expression of SPF in mouse and rat liver was 
confirmed by immunoblotting.  A reasonable amount of protein was detected in both 
mouse and rat liver cytosol.  This also demonstrated that the GenWay Sec14l2 antibody 
against human SPF detects proteins of the same size from mouse and rat (Fig. 4.6). 
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Figure 4.6: SPF protein is present in rat and mouse liver cytosol.  Immunoblot 
developed with rabbit anti-human Sec14l2 antibody (GenWay Biotech, Inc.).  
 
Mouse primary hepatocytes were prepared as described in the Materials and Methods 
section and plated on collagen-coated coverslips.  The next day the cells were fixed and 
processed for immunofluorescent staining (Fig.4.7).  
It should be noted that there was no negative control in studies on primary hepatocytes, 
as all were expected to express SPF.  However, the conditions for immunofluorescence 
were optimized earlier on McARH7777 cells, where endogenous SPF protein could not 
be detected. 
88 
 
 
Figure 4.7: Endogenous mouse SPF protein (red) localizes to the cytosol.  Red, Sec14l2 
antibody signal; blue, DAPI nuclear stain. 
 
It appeared that endogenous SPF protein, as anticipated, is present ubiquitously in the 
cytosol.  To see if endogenous SPF protein moves in response to the treatments 
described earlier, cells were treated for 3 hours with dbcAMP, PKAi (inhibitor), brefeldin 
A, or α-tocopherol and processed for immunostaining.  
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Figure 4.8: SPF protein localizes to cytosol in mouse primary hepatocytes and does not 
relocate in response to various treatments.  Treatments: A) none; B) 0.2 mM dbcAMP; 
C) 0.1 µM PKAi; D) 100 nM brefeldin A; E) 50 µM α-tocopherol. Green –Sec14l2 antibody 
signal; blue –DAPI nuclear stain. 
  
Analysis by confocal microscopy showed no evident change in protein subcellular 
localization (Fig. 4.8).   
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Summarizing, I conclude that SPF either does not translocate in response to these 
treatments or that perhaps only a small portion of the protein was responsible for the 
effect on cholesterol synthesis and only this protein relocates within the cell, and that 
this limited movement cannot be detected by immunostaining.  Perhaps subcellular 
fractionation and subsequent analysis of SPF content after these treatments would 
reveal relative changes in localization, as well as the membrane structures involved. 
This finding was a bit surprising, as the effect of these treatments clearly affected the 
ability of SPF to stimulate cholesterol synthesis 21; 22.  It would appear that SPF is 
relatively highly expressed in hepatocytes, an observation consistent with early 
enzymology studies that demonstrated an abundance of this protein in cytosol.  The 
abundance of this protein would obscure subcellular changes in a small proportion of 
the protein.   
 
 
 
 
 
 
 
 
 
 
Copyright © Elzbieta Ilona Stolarczyk 2009 
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Chapter 5 :  REGULATION OF SPF EXPRESSION IN RAT HEPATOMA CELLS 
 
 
INTRODUCTION 
 
Shibata et al. 24 found that plasma lipids levels were unchanged in SPF-null mice, despite 
elevated levels of HMG-CoA synthase and squalene monooxygenase in liver.  However, 
during fasting plasma cholesterol levels decreased significantly in SPF-null mice, but not 
in wild-type mice.  Fasting decreased hepatic cholesterol synthesis in both wild-type and 
SPF-null animals, with a greater reduction in SPF-null mice.  The decrease in cholesterol 
synthesis likely resulted from a pronounced decrease in the expression of the 
cholesterolgenic enzymes HMG-CoA synthase, HMG-CoA reductase, and squalene 
monooxygenase in both wild-type and knockout mice.  Notably, in fasted wild-type 
mice, expression of SPF mRNA and protein was elevated.  
The data from SPF-null mice strongly suggests that SPF is upregulated upon fasting to 
compensate, at least partially, for the decrease in cholesterol synthesis.  The reason for 
this compensatory increase is not clear.  In agreement with these observations, previous 
data from our lab have shown that SPF activity was decreased by about 50% in rats fed 
high fat diet and returned to normal upon return to normal chow diet 21.  The decrease 
in expression was suggested to explain the decrease in SPF activity in liver preparations 
from the high-fat diet animals, since activity could not be increased by in vitro 
phosphorylation 21, which this laboratory has shown to be able to activate SPF 21; 22.  
These results are in agreement with studies from SPF-null mice and suggest that 
upregulation of SPF expression during fasting might be attributed, at least in part, to 
removal of lipids from the diet. 
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The gene that was deleted in SPF-null mice is a mouse SPF (mSec14l2), an ortholog of 
the human SPF1 gene (hSec14l2) with 93% identity.  The studies described below were 
conducted in rat hepatoma cells, in which there are two established rat orthologs of 
SPF: rat SPF (rSec14l2, with 94% identity to human SPF1) and rat SPF-like protein 
(rSec14l3/p45, with 97% identity to human SPF2).   
SREBPs, Sterol Regulatory Element Binding Proteins, are membrane-bound transcription 
factors that are master regulators of fatty acid and cholesterol biosynthesis.  SREBP-1a 
regulates enzymes responsible for biosynthesis of fatty acids and cholesterol, SREBP-1c 
is specific for fatty acid biosynthesis, and SREBP-2 regulates cholesterol biosynthesis.  
While SREBPs activate the transcription of genes responsible for sterol and fatty acid 
synthesis in response to low levels of these lipids, the LXR-dependent regulatory 
pathway is activated in response to elevated cellular sterols.  Oxysterols, which are 
oxidized derivatives of cholesterol, are the known endogenous ligands for the LXR 
nuclear receptor.  The LXRα receptor increases the expression of cholesterol efflux 
genes and decreases cholesterol uptake and synthesis by suppressing SREBP activation, 
and accelerating HMG-CoA reductase degradation 49
Fasting decreased hepatic cholesterol synthesis in both wild-type and SPF-deficient 
animals with a greater reduction in knockout mice 
. 
The following studies were undertaken to gain insight into the mechanisms that govern 
the expression of SPF proteins. 
 
Experimental Rationale 
24.  The decrease in the cholesterol 
synthesis rate was accompanied by a pronounced decrease in the expression of 
cholesterolgenic enzymes: HMG-CoA synthase, HMG-CoA reductase, and squalene 
monooxygenase.  Expression of the SPF transcript and protein was elevated in wild-type 
mice during starvation.  I hypothesized that serum deprivation similarly will induce 
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expression of SPF in a hepatoma cell line, mimicking starvation in mice, facilitating 
studies on the regulation of SPF in a cell culture system.  Putative nuclear receptors 
regulating SPF expression also will be identified. 
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MATERIALS AND METHODS 
 
Materials 
Cholesterol, hydroxypropyl-β-cyclodextrin, 25-hydroxycholesterol, 22(S)-hydroxy-
cholesterol, and GW3965 were purchased from Sigma-Aldrich, Inc. 
Preparation of cholesterol: cyclodextrin complexes.  Cholesterol was dissolved in ethanol 
(5 mg/ml) and 1 ml of that solution was dried under liquid nitrogen.  Two ml of 5% 
hydroxypropyl-β-cyclodextrin solution in water was added to the cholesterol and the 
mixture was sonicated in a water bath at room temperature until the solution was 
clarified. 
 
Cell culture 
 McARH7777 rat hepatoma cells were cultured in Dulbecco's Modified Eagle Medium 
(Gibco) supplemented with 1x Penicillin-Streptomycin mixture (Invitrogen) and 10% 
Fetal Bovine Serum (Invitrogen), unless otherwise stated. 
Preparation of Lipid-Deficient Serum.  One volume of Fetal Bovine Serum (Invitrogen) 
was mixed with one volume of diethyl ether and vortexed vigorously.  The ether fraction 
containing the lipids was removed and the delipidated serum was used for cell culture. 
 
RT-PCR 
Total RNA was isolated from cells with use of TRIzol reagent (Invitrogen) and the 
concentration of RNA was measured spectrophotometrically with use of the Nanodrop 
instrument (Thermo Scientific).  The reverse transcriptase reaction and real-time PCR 
were performed as described in Materials and Methods in Chapter 2.  Gene-specific 
primers for real-time PCR were designed using ABI Prism Primer Express software 
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(Applied Biosystems).  The sequences of the primers are displayed in Table 5.1.  Results 
were analyzed with use of Comparative Ct method 50
Table 5.1: Gene-specific primers used in real-time PCR. 
 
. 
 
Gene Primers 
Β actin Fw: 5’-CCGTGAAAAGATGACCCAGATC-3’ 
Rv: 5’-AATGCCAGTGGTACGACCAGA-3’ 
HMGcr Fw: 5’- TCATCCTCACGATAACCCGGT-3’ 
Rv: 5’- GGCCGGCAATACCCAAAAT-3’ 
rSec14l2 Fw: 5’- AATTCCCACATGGTCCCTGAG-3’  
Rv: 5’- ACTTTCTTGGCATGGATGAAGC-3’  
rSec14l3 Fw: 5’- CAGTATGAGCACTCGGTGCAGA-3’ 
Rv: 5’- GCTCCATCAGATGAGAACTGCC-3’ 
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RESULTS AND DISCUSSION 
 
As fasting up-regulated the hepatic expression of SPF in mice 24, I wanted to generate an 
in vitro model using cultured hepatoma cells.  To do this I started by changing the 
concentration of glucose in the media and looking at its effect on SPF and HMG-CoA 
reductase expression in treated cells.  McARH7777 rat hepatoma cells are usually 
cultured in high glucose (4.5 g/L) media; I cultured these cells at a low concentration of 
glucose (1 g/L).  After 48 hours RNA was isolated from the cells and the expression of 
HMG-CoA reductase and the two rat SPF genes (Sec14l2 and Sec14l3) was assessed by 
real-time PCR.  Although I anticipated an increase in SPF expression when the glucose 
concentration was reduced (as is seen in fasting), lowering the glucose concentration in 
the media had no significant effect on mRNA levels for HMG-CoA reductase or either 
SPF gene; indeed, a trend toward a decrease in expression was seen (Fig. 5.1, orange 
bars).  Since this data showed that a reduction in the glucose concentration does not 
result in the upregulation of SPF genes, I concluded that these conditions may not 
appropriately mimic the fasting state in mice.  This led to the conclusion that fasting 
may alter other components of serum, including hormones and other nutrients; changes 
in the level of these components may be responsible for the changes seen in SPF 
expression in fasted animals.  Since very little is known about SPF regulation, and serum 
has multiple components, I decided to explore the role of serum in SPF expression.  
When cultured hepatoma cells were maintained in serum-free medium for 48 h the 
expression of both rat SPF genes was increased while HMG-CoA reductase expression 
remained unchanged (Fig. 5.1, red bars).  The increase in SPF transcripts was less than 
100%, but statistically significant.  Interestingly, when cells were cultured in low glucose 
and serum-free media the increase in both SPF transcripts was more dramatic (Fig.5.1, 
brown bars), indicating that removal of glucose potentiates the effect serum. 
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This result supported the hypothesis that the increases in SPF expression induced by 
fasting might be mediated by changes in serum components.  
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Figure 5.1: Serum removal results in an increase in the expression of SPF proteins in 
rat hepatoma cells; this effect is potentiated by removal of glucose.  Cells were 
cultured for 48 h in high or low glucose, with or without FBS.  HG, high glucose; LG, low 
glucose; FBS, fetal bovine serum; HMGcr, HMG-CoA reductase.  Statistical analysis 
performed by ANOVA, (*) p<0.05; (**) p<0.0001; N, number of experiments run in 
duplicate. 
 
To address this possibility, I have tried to identify the components of serum that could 
alter SPF gene expression.  Since SPF is known to upregulate cholesterol synthesis, I 
hypothesized that a decrease in serum cholesterol levels might upregulate SPF 
expression.  As expected, when hepatoma cells were cultured in medium containing 
serum from which the majority of lipids had been removed (lipid-deficient serum, LDS), 
the expression of both SPF genes and HMG-CoA reductase was increased, although the 
increase was not statistically significant (Fig. 5.2).   
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Figure 5.2: Effect of delipidated serum on HMG-CoA reductase and SPF gene 
expression.  Cells were cultured for 48 h in high-glucose media in the presence of 
normal (FBS) or delipidated (LDS) serum; n = 5.   
 
By the same logic, since high cholesterol levels inhibit cholesterol synthesis through 
negative feedback regulation, it was anticipated that SPF and HMG-CoA reductase 
expression would be suppressed upon supplementation of the media with a mixture of 
cholesterol:25-hydroxycholesterol (10:1 µg/ml). Both cholesterol and 25-
hydroxycholesterol downregulate cholesterol biosynthesis via inhibition of SREBP 
processing 51.  Indeed, as shown in Fig. 5.3, supplementation of the media with a mixture 
of cholesterol:25-hydroxycholesterol resulted in a decrease in the expression of HMG-
CoA reductase and both SPF genes by up to 50%.  These results indicate that the 
expression of both SPF genes depends on cholesterol availability, and suggest that the 
upregulation of SPF gene expression upon serum deprivation may result, at least in part, 
from the loss of cholesterol in the medium.   
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Figure 5.3: Sterol supplementation decreases SPF expression.  Cells were cultured for 
48 h in high-glucose media in the presence or absence of FBS and a cholesterol/25-
hydroxycholesterol mixture.  FBS, fetal bovine serum; 25-HC, 25-hydroxycholesterol; n = 
2. 
 
As shown above, a mixture of cholesterol:25-hydroxycholesterol decreased the 
expression of SPF genes in the presence and absence of serum.  Since both of these 
compounds inhibit the SREBP pathway but 25-hydroxycholesterol is also a ligand for LXR 
receptor52, these results raised the question as to whether SPF gene expression is 
regulated by SREBP or LXR.  To test the role of the LXR in SPF regulation, a specific LXR 
agonist, GW3965, was added to cells cultured in the absence of serum.  If LXR activation 
suppresses SPF expression the addition of an LXR agonist should prevent or reverse the 
induction of SPF gene expression by serum deprivation.  However, as shown in Fig. 5.4, 
the LXR agonist was unable to prevent the increase in SPF expression in these cells.  This 
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result suggests that cholesterol (and 25-hydroxycholesterol) act through the SREBP 
pathway, rather than the LXR pathway, to suppress SPF expression. 
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Figure 5.4: LXR ligand does not change the effect of serum and glucose removal on SPF 
expression.  Cells were cultured in low-glucose media.  FBS-fetal bovine serum; 
GW3965, LXR receptor agonist; n = 2. 
 
Summarizing, my studies in rat hepatoma cells have shown that expression of both rat 
SPF genes is upregulated in response to serum removal, which is potentiated by removal 
of glucose.  Also, my studies have shown that lipids, most likely cholesterol, are the 
likely components of serum whose absence contributes to the increase in SPF 
transcripts.  These results are consistent with a role for SPF in upregulating cholesterol 
synthesis in hepatoma cells.   
To further explore the effect of serum and glucose removal on SPF expression, I 
attempted to identify transcription factors that regulate the transcription of the SPF 
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genes.  LXR, SREBP and/or PPARα were considered to be likely candidates.  My studies 
show that LXR is most likely not the transcription factor governing expression of SPF 
genes in my cell culture system, as addition of an LXR agonist did not suppress SPF 
expression.  The possibility of regulation via SREBP remains to be tested.  Moreover, the 
possibility that SPF gene expression is regulated differently in cell culture than in a 
whole animal must also be considered. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Elzbieta Ilona Stolarczyk 2009 
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Chapter 6 :  SUMMARY OF RESEARCH 
 
 
SPF is a cytosolic protein known to stimulate cholesterol biosynthesis.  HMG-CoA 
reductase, squalene monooxygenase and oxidosqualene cyclase are the three enzymes 
of the cholesterol biosynthetic pathway that are known to be stimulated by SPF.  The 
mechanism of SPF action is not yet well understood.  More recent studies have revealed 
that there are three highly similar SPF genes in the human genome.  They encode three 
homologous proteins: SPF1, SPF2 and SPF3.  The protein that has been studied the most 
to date is SPF1.  Little is known about the expression of the other two SPF proteins and 
nothing is known about their function.  To gain insight into possible functions for these 
proteins, I utilized three different approaches to determine which tissues express SPF 
genes.  In all, over 75 tissues were screened for expression of SPF mRNA, using highly 
sensitive probes designed to detect each SPF gene transcript with high specificity.  SPF 
expression was most evident in liver, stomach, and mammary tissue, with levels in liver 
being at least 50-fold higher than those found in other tissues.  My studies further show 
that, of the three SPF transcripts, SPF1 is the most abundant, followed by approximately 
20-fold lower expression of SPF3 and negligible expression of SPF2.  Although I had 
hoped to uncover differential expression of these genes in various tissues suggestive of 
functional differences, the expression patterns did not support this hypothesis.  In all 
tissues where SPF was present, SPF1 expression dominated, suggesting that SPF2 and 
SPF3 were either non-functional, of marginal importance, or were expressed only in 
specific conditions or developmental stages.  Further studies will be needed to identify 
any such conditions. 
The SPF2 transcript could only be detected in human liver and its level was very low 
when compared with SPF1 and SPF3.  Full-length SPF2 could not be cloned and 
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therefore I was unable to assess its ability to stimulate cholesterol synthesis.  The fact 
that p45 protein, a rat ortholog of human SPF2, was able to stimulate cholesterol 
synthesis 38
SPF was shown to require phosphorylation and the presence of Golgi structures in order 
to stimulate cholesterol synthesis in rat hepatoma cells 
, suggests that human SPF2 might have similar ability.  This question remains 
to be answered in future studies.  However, given the negligible expression levels in all 
tested tissues, it is reasonable to discount SPF2 as a factor contributing to the 
stimulatory effect of SPF on cholesterol biosynthesis in liver.  The possibility remains 
that SPF2 is expressed in other, as yet untested tissues, or that its expression is induced 
in response to certain stimuli or conditions.  Both of these possibilities remain to be 
tested.  My studies revealed that human SPF3 protein is capable of stimulating 
cholesterol synthesis in cell culture, although it appears somewhat less effective than 
SPF1, and is unable to stimulate squalene monooxygenase activity in microsomal 
preparations.  This finding suggests that SPF3 may act only on HMG-CoA reductase, in 
contrast to SPF1, which stimulates both squalene monooxygenase and HMG-CoA 
reductase, as well as oxidosqualene cyclase.  The possibility that SPF3 activates HMG-
CoA reductase in vitro remains to be determined.  Overall, the limited expression of 
SPF3 in all tissues including liver suggests that, like SPF2, the protein does not play a 
significant role in regulating cholesterol synthesis, although it remains possible that its 
expression is upregulated, perhaps in select tissues, in response to environmental, 
hormonal, or developmental stimuli.  In the absence of such data, I conclude that SPF1 
should be considered as a main human SPF homolog responsible for stimulating 
cholesterol synthesis in liver. 
22.  It was hypothesized that, 
once activated by phosphorylation, SPF associates with some membranous 
compartment, perhaps the endoplasmic reticulum (ER), in order to stimulate the 
enzymes of the cholesterolgenic pathway, which are membrane-bound proteins.  I 
anticipated that in response to protein kinase A-mediated phosphorylation induced by 
adding dbcAMP to rat hepatoma cells, SPF will associate with some membrane 
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compartment and that this change in localization would be captured by my 
immunocytochemistry studies; by comparison, the phosphorylation mutant SPF1S289A, 
which cannot be phosphorylated, and the wild-type protein in cells treated with a PKA 
inhibitor, will fail to translocate.  However, my studies in rat hepatoma cells revealed no 
noticeable change in protein localization inside the cell in response to these treatments.  
Disruption of Golgi by brefeldin A in rat hepatoma cells was shown to abolish the 
stimulatory effect of heterologously expressed SPF protein on cholesterol synthesis 22. 
Similarly, SPF protein lacking the GOLD domain (SPF1del111), thought to mediate Golgi 
interactions, was also unable to stimulate cholesterol synthesis 22. I anticipated that 
these effects would be reflected by changes in protein cellular localization.  Treatment 
with brefeldin A did result in disruption of Golgi structures, but no change in SPF protein 
localization was observed.  Transfections with a GOLD domain mutant resulted in a 
protein localizing mainly to the large vesicular structures around nuclei, different from 
Golgi, suggesting that remaining Sec14 domain may contain signal targeting to these 
vesicular structures. 
To rule out the possibility that the change in subcellular localization could not be 
detected due to the abundance of overexpressed protein in transfected cells, or 
because the recombinant protein behaves differently than the endogenous one, I 
decided to test the effect of the above treatments on the endogenous SPF.  To do so I 
isolated primary hepatocytes from mice and performed these treatments on these cells; 
once again, however, I did not observe a change in the SPF subcellular location.  These 
results led to the conclusion that SPF either does not translocate in response to these 
treatments or that perhaps only a small portion of the protein was responsible for the 
effect on cholesterol synthesis and only this protein relocates within the cell, and that is 
why the movement cannot be detected by immunostaining.  Perhaps subcellular 
fractionation and subsequent analysis of SPF content after these treatments would 
reveal relative changes in localization, as well as the membrane structures involved. 
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 SPF-null mice had previously been shown to develop normally, and their plasma lipids 
are unchanged 24.  However when tested by food restriction, plasma cholesterol levels 
decreased significantly in these mice, but not in wild-type mice.  Interestingly, in starved 
wild-type mice expression of mouse SPF protein was elevated.  These findings strongly 
suggested that SPF is a “buffering” protein, responsible for maintaining plasma 
cholesterol levels during short-term starvation 24
To further explore the effect of serum and glucose removal on SPF expression, I 
attempted to identify transcription factors that regulate the transcription of SPF genes.  
LXR, SREBP and/or PPARα were considered to be likely candidates.  Peroxisome 
proliferator-activated receptor alpha (PPARα) was recognized as critical regulatory 
element directing cellular responses to fasting 
.  In my studies in rat hepatoma cells I 
found that expression of both rat SPF genes is upregulated in response to serum 
removal, which is potentiated by removal of glucose.  This effect of glucose is puzzling; 
glucose removal potentiated the effect of serum removal on SPF gene expression, but 
glucose removal alone did not significantly increase SPF expression.  My studies have 
shown that lipids/cholesterol are the likely components of serum whose absence 
contributes to the increase in SPF transcripts; first, when hepatoma cells were cultured 
in delipidated serum SPF transcripts were increased; and second, supplementation of 
media with a mixture of cholesterol:25-hydroxycholesterol decreased the levels of SPF 
and HMG-CoA reductase transcripts.  These results are consistent with a role for SPF in 
upregulating cholesterol synthesis in hepatoma cells.  I also investigated the possible 
role of insulin in SPF regulation, but media supplementation with insulin did not appear 
to alter SPF gene expression.  
25; 26.  In fact, Shibata at al. 24 showed that 
during starvation SPF expression is elevated in wild-type mice, but not in PPARα-null 
mice, suggesting that PPARα acts upstream of SPF expression.  I have begun to test this 
hypothesis in our cell culture model by treating cells with PPARα agonists, which were 
expected to induce SPF gene expression.  Preliminary data (not shown) did not support 
this hypothesis, but further investigation is needed to rule out this hypothesis 
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completely.  The possibility that SPF gene expression is regulated differently in cell 
culture than in a whole animal must also be considered.  My studies show that LXR is 
most likely not the transcription factor governing expression of SPF genes in my cell 
culture system, as addition of an LXR agonist did not suppress SPF expression.  The 
possibility of regulation via SREBP remains to be tested.  
The mechanism of the SPF stimulatory effect on cholesterol synthesis remains to be 
elucidated.  The fact that this protein stimulates three different enzymes of the 
cholesterolgenic pathway implies some general mechanism.  All three enzymes are 
membrane-bound proteins and it was demonstrated earlier that, at least for squalene 
monooxygenase, SPF does not stimulate the solubilized enzyme, but only the 
membrane-bound form, suggesting some membrane-dependent event 7.  Notably, SPF 
has two relevant domains: Sec14, a lipid binding domain, and a GOLD domain, proposed 
to mediate protein-protein interactions involved in Golgi function.  It is predicted that 
such two-domain proteins may serve as adaptor proteins in assembling protein 
complexes on membranes, or perhaps help in cargo packaging into membrane vesicles 
48.  In fact, p45 protein, the rat homolog of human SPF2, was shown to be concentrated 
in secretory vesicles in COS-1 cells and secreted from the cell 48.  In further support of 
this contention is the observation that the most likely ligand for SPF, 
phosphatidylinositol (PI), is a lipid that resides in the membrane, and therefore to bind 
this ligand SPF has to associate with phosphatidylinositol-rich membranes.  Since PI was 
identified as the most likely ligand for SPF 27, and there are several phosphorylated 
derivatives of PI in the cell, it should be further explored whether one of these 
phosphorylated PIs has a higher affinity for SPF than PI.  In support of this hypothesis 
lies the finding that PI(3,4,5)P3 was identified as a lipid ligand of rat p45 protein 48
Also, the link of SPF protein with phosphatidylinositol-3-kinase (PIP3K) remains to be 
explored.  SPF was earlier coprecipitated with PI3K and was shown to decrease the 
.  
Identification of a true physiologic ligand would be helpful in further investigations on 
the mechanism of action of SPF.  
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activity of this kinase 31.  Later, another study showed that SPF inhibits prostate cancer 
cell growth via inhibition of PI3K/Akt pathway 40.  It would be interesting to test whether 
overexpression of SPF in hepatocellular carcinoma cells would also result in inhibition of 
cell division.  Indeed, SPF expression in rat hepatoma cells is very low when compared 
with normal liver tissue, which is consistent with this hypothesis.  Presently it is unclear 
if the SPF inhibitory effect on the PI3K pathway is linked to its ability to stimulate 
cholesterol synthesis; further studies in this direction are warranted. 
In the light of current knowledge on SPF, it is reasonable to think that SPF participates in 
the assembly or trafficking of some membrane vesicles, perhaps containing substrates 
for the enzymes it stimulates; or by influencing the properties of the ER membrane in 
such a way that it creates more favorable conditions for the catalyzed reactions to 
occur.  It is also possible that the stimulatory effect on cholesterol synthesis is not the 
primary function of SPF, but rather a “collateral” effect of another action.  Also, the 
stimulatory effect on cholesterol synthesis was shown so far only in liver-derived cells, 
making it possible that it is the only site of this type of SPF activity.  Therefore, given the 
several different reports on SPF function, including its ability to inhibit the PI3K pathway 
31; 40, its ability to retain vitamin E inside the cell 40, and its ability to stimulate enzymes of 
cholesterol biosynthetic pathway, it would be reasonable to think that perhaps the 
function of SPF is cell-type specific, and depends on the availability of other proteins 
with which SPF interacts.  
 
 
 
 
Copyright © Elzbieta Ilona Stolarczyk 2009 
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